<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
<journal-id journal-id-type="publisher-id">ijms</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Sciences</journal-title>
</journal-title-group>
<issn pub-type="epub">1422-0067</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28665350</article-id>
<article-id pub-id-type="pmc">5535897</article-id>
<article-id pub-id-type="doi">10.3390/ijms18071404</article-id>
<article-id pub-id-type="publisher-id">ijms-18-01404</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Histone Lysine Methylation and Neurodevelopmental Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Jeong-Hoon</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-18-01404">1</xref>
<xref ref-type="aff" rid="af2-ijms-18-01404">2</xref>
<xref ref-type="author-notes" rid="fn1-ijms-18-01404">†</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5659-2816</contrib-id>
<name>
<surname>Lee</surname>
<given-names>Jang Ho</given-names>
</name>
<xref ref-type="aff" rid="af3-ijms-18-01404">3</xref>
<xref ref-type="author-notes" rid="fn1-ijms-18-01404">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Im-Soon</given-names>
</name>
<xref ref-type="aff" rid="af3-ijms-18-01404">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Sung Bae</given-names>
</name>
<xref ref-type="aff" rid="af4-ijms-18-01404">4</xref>
<xref ref-type="corresp" rid="c1-ijms-18-01404">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cho</surname>
<given-names>Kyoung Sang</given-names>
</name>
<xref ref-type="aff" rid="af3-ijms-18-01404">3</xref>
<xref ref-type="corresp" rid="c1-ijms-18-01404">*</xref>
</contrib>
</contrib-group>
<aff id="af1-ijms-18-01404"><label>1</label>Personalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Korea; <email>jhoonkim@kribb.re.kr</email></aff>
<aff id="af2-ijms-18-01404"><label>2</label>Department of Functional Genomics, University of Science and Technology, Daejeon 34113, Korea</aff>
<aff id="af3-ijms-18-01404"><label>3</label>Department of Biological Sciences, Konkuk University, Seoul 05029, Korea; <email>kingmega@konkuk.ac.kr</email> (J.H.L.); <email>islee@konkuk.ac.kr</email> (I.-S.L.)</aff>
<aff id="af4-ijms-18-01404"><label>4</label>Department of Brain &amp; Cognitive Sciences, DGIST, Daegu 42988, Korea</aff>
<author-notes>
<corresp id="c1-ijms-18-01404"><label>*</label>Correspondence: <email>sblee@dgist.ac.kr</email> (S.B.L.); <email>kscho@konkuk.ac.kr</email> (K.S.C.); Tel.: + 82-53-785-6122 (S.B.L.); +82-2-450-3424 (K.S.C.)</corresp>
<fn id="fn1-ijms-18-01404">
<label>†</label>
<p>These authors contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>30</day>
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<month>7</month>
<year>2017</year>
</pub-date>
<volume>18</volume>
<issue>7</issue>
<elocation-id>1404</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>6</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>6</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© 2017 by the authors.</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Methylation of several lysine residues of histones is a crucial mechanism for relatively long-term regulation of genomic activity. Recent molecular biological studies have demonstrated that the function of histone methylation is more diverse and complex than previously thought. Moreover, studies using newly available genomics techniques, such as exome sequencing, have identified an increasing number of histone lysine methylation-related genes as intellectual disability-associated genes, which highlights the importance of accurate control of histone methylation during neurogenesis. However, given the functional diversity and complexity of histone methylation within the cell, the study of the molecular basis of histone methylation-related neurodevelopmental disorders is currently still in its infancy. Here, we review the latest studies that revealed the pathological implications of alterations in histone methylation status in the context of various neurodevelopmental disorders and propose possible therapeutic application of epigenetic compounds regulating histone methylation status for the treatment of these diseases.</p>
</abstract>
<kwd-group>
<kwd>epigenetic changes</kwd>
<kwd>histone lysine methylation</kwd>
<kwd>lysine methyltransferase</kwd>
<kwd>lysine demethylase</kwd>
<kwd>neurodevelopmental disorder</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-ijms-18-01404">
<title>1. Introduction</title>
<p>Post-translational modifications of histone proteins in eukaryotic cells serve as crucial regulatory mechanisms of gene expression and are important for maintaining genomic integrity [<xref ref-type="bibr" rid="B1-ijms-18-01404">1</xref>,<xref ref-type="bibr" rid="B2-ijms-18-01404">2</xref>]. The histone modifications, such as its acetylation, methylation, phosphorylation, and ubiquitination, influence genomic activity by altering the binding force of DNA to histones or by acting as marks that recruit specific histone binding proteins [<xref ref-type="bibr" rid="B2-ijms-18-01404">2</xref>]. Among these histone modifications, methylation has been implicated in heterochromatin formation and the regulation of promoter activity [<xref ref-type="bibr" rid="B3-ijms-18-01404">3</xref>,<xref ref-type="bibr" rid="B4-ijms-18-01404">4</xref>]. The histone residues, on which methylation occurs, include the following lysine and arginine residues: H3 (K4, 9, 27, 36, and 79), H4K20, H3 (R2, 8, 17, and 26), and H4R3 [<xref ref-type="bibr" rid="B5-ijms-18-01404">5</xref>,<xref ref-type="bibr" rid="B6-ijms-18-01404">6</xref>] (<xref ref-type="fig" rid="ijms-18-01404-f001">Figure 1</xref>a). These methylation sites are evolutionarily well conserved [<xref ref-type="bibr" rid="B7-ijms-18-01404">7</xref>]. A variety of histone methyltransferases (writers), histone demethylases (erasers), and methylated histone binding proteins (readers) have been identified in various eukaryotic genomes [<xref ref-type="bibr" rid="B8-ijms-18-01404">8</xref>]. Their site-specific molecular functions have been defined by biochemical and genetic studies [<xref ref-type="bibr" rid="B2-ijms-18-01404">2</xref>,<xref ref-type="bibr" rid="B8-ijms-18-01404">8</xref>] (<xref ref-type="table" rid="ijms-18-01404-t001">Table 1</xref>).</p>
<p>Dysregulation of epigenetic modifications are associated with various human diseases, including neurodevelopmental disorders [<xref ref-type="bibr" rid="B9-ijms-18-01404">9</xref>,<xref ref-type="bibr" rid="B10-ijms-18-01404">10</xref>]. In particular, an increasing number of mutations in histone lysine methylation-related genes have been identified as intellectual disability-associated genes by exome sequencing with patients’ samples [<xref ref-type="bibr" rid="B11-ijms-18-01404">11</xref>,<xref ref-type="bibr" rid="B12-ijms-18-01404">12</xref>,<xref ref-type="bibr" rid="B13-ijms-18-01404">13</xref>,<xref ref-type="bibr" rid="B14-ijms-18-01404">14</xref>] (<xref ref-type="fig" rid="ijms-18-01404-f001">Figure 1</xref>b and <xref ref-type="table" rid="ijms-18-01404-t002">Table 2</xref>). This highlights the importance of proper control of histone methylation during neurogenesis. In the current article, we provide an overview of the latest updates on the pathological implication of alterations in histone lysine methylation status in terms of neurodevelopmental disorders. Through this, we try to predict the future direction of research on this emerging field.</p>
</sec>
<sec id="sec2-ijms-18-01404">
<title>2. Histone Lysine Methylations and Related Factors</title>
<p>In most cases, methylation of histone H3 lysine 4 (H3K4me) is primarily found at enhancers and promoters of actively transcribed genes, and the methylation status of genes (i.e., mono-, di-, tri-methylation) correlates with its transcriptional activity [<xref ref-type="bibr" rid="B15-ijms-18-01404">15</xref>,<xref ref-type="bibr" rid="B16-ijms-18-01404">16</xref>]. Members of the lysine methyl transferase 2 (KMT2) family catalyze the addition of methyl groups to H3K4 at the post-translational level, while lysine demethylases (KDMs) remove the methyl groups. This dynamically modulates chromatin structures [<xref ref-type="bibr" rid="B17-ijms-18-01404">17</xref>,<xref ref-type="bibr" rid="B18-ijms-18-01404">18</xref>]. The KMT2 family, which is highly conserved throughout eukaryotes, can be evolutionarily divided into three subgroups (i.e., KMT2A and KMT2B, KMT2C and KMT2D, and SETD1A and SETD1B) [<xref ref-type="bibr" rid="B4-ijms-18-01404">4</xref>,<xref ref-type="bibr" rid="B19-ijms-18-01404">19</xref>]. In addition, SMYD2 and SETD3 also have been identified as H3K4 methyltransferases, and eight KDMs are reported to target the H3K4me [<xref ref-type="bibr" rid="B4-ijms-18-01404">4</xref>,<xref ref-type="bibr" rid="B20-ijms-18-01404">20</xref>].</p>
<p>Methylation of histone H3 lysine 9 (H3K9me) is associated with both heterochromatin formation and gene silencing in euchromatin [<xref ref-type="bibr" rid="B2-ijms-18-01404">2</xref>]. H3K9me acts as a binding sit <italic>Counseling</italic>, e for HP1 [<xref ref-type="bibr" rid="B21-ijms-18-01404">21</xref>,<xref ref-type="bibr" rid="B22-ijms-18-01404">22</xref>] which forms a complex with chromatin-modifying factors crucial for heterochromatin formation when recruited to H3K9me [<xref ref-type="bibr" rid="B23-ijms-18-01404">23</xref>,<xref ref-type="bibr" rid="B24-ijms-18-01404">24</xref>]. In the euchromatic region, H3K9me contributes to HP1-mediated gene silencing [<xref ref-type="bibr" rid="B25-ijms-18-01404">25</xref>]. H3K9me is catalyzed by several methyltransferases, such as EHMT1, EHMT2, SUV39H1, SUV39H2, SETDB1, dimeric EHMT1-EHMT2, and the PRDM family, and erased by the following lysine demethylases: KDM1, KDM3, KDM4, PHF2, and PHF8 [<xref ref-type="bibr" rid="B8-ijms-18-01404">8</xref>,<xref ref-type="bibr" rid="B26-ijms-18-01404">26</xref>,<xref ref-type="bibr" rid="B27-ijms-18-01404">27</xref>].</p>
<p>Histone H3 lysine 27 methylation (H3K27me) is a repressive chromatin mark that is involved in gene silencing during development and X-chromosome inactivation [<xref ref-type="bibr" rid="B28-ijms-18-01404">28</xref>,<xref ref-type="bibr" rid="B29-ijms-18-01404">29</xref>]. H3K27me is associated with the repression of developmental regulator genes in human and murine embryonic stem cells (ESCs) [<xref ref-type="bibr" rid="B30-ijms-18-01404">30</xref>,<xref ref-type="bibr" rid="B31-ijms-18-01404">31</xref>]. Intriguingly, a variety of promoters characteristically contain both H3K4me3 (an activating mark) and H3K27me (a repressive mark) in pluripotent ESCs, which is referred to as “bivalency.” The change in the bivalent situation is associated with differentiation [<xref ref-type="bibr" rid="B32-ijms-18-01404">32</xref>]. H3K27me, catalyzed by EZH1 or EZH2 containing Polycomb Repressive Complex (PRC) 2, is a binding site for PRC1 to compact chromosomes [<xref ref-type="bibr" rid="B33-ijms-18-01404">33</xref>]. KDM6A, KDM6B, and UTY have been identified as erasers of H3K27me [<xref ref-type="bibr" rid="B8-ijms-18-01404">8</xref>].</p>
<p>A role of methylation on histone H3 lysine 36 (H3K36me) has initially been reported in the activation of genes in various systems [<xref ref-type="bibr" rid="B34-ijms-18-01404">34</xref>]. However, H3K36me also functions in various processes, including alternative splicing [<xref ref-type="bibr" rid="B35-ijms-18-01404">35</xref>], dosage compensation [<xref ref-type="bibr" rid="B36-ijms-18-01404">36</xref>], DNA damage response [<xref ref-type="bibr" rid="B37-ijms-18-01404">37</xref>], and transcriptional repression [<xref ref-type="bibr" rid="B38-ijms-18-01404">38</xref>], depending on the chromatin context. H3K36me is tightly regulated by multiple KMTs and KDMs [<xref ref-type="bibr" rid="B20-ijms-18-01404">20</xref>]. In vitro and in vivo studies, to date, have demonstrated that there are the following eight types of KMTs regulating H3K36 methylation levels in humans: SETD2, SETD3, NSD1, NSD2, NSD3, ASH1L, SMYD2, and SETMAR [<xref ref-type="bibr" rid="B20-ijms-18-01404">20</xref>]. Although all H3K36-specific methyltransferases contain highly conserved SET domains, the patterns of H3K36 methylation vary. Most H3K36 KMTs preferentially mono- and di-methylate the residue, whereas SETD2 is the only enzyme that catalyzes H3K36me3 and requires mono- or di-methylated H3K36 for its function [<xref ref-type="bibr" rid="B39-ijms-18-01404">39</xref>]. Conversely, methylated H3K36 can be demethylated by six KDMs. The H3K36 KDMs, which all belong to the Jumonji protein family, contain the conserved JmjC domain consisting of the following three groups: JHDM1 (KDM2A, KDM2B), JHDM3 (KDM4A, KDM4B, KDM4C), and RIOX1 [<xref ref-type="bibr" rid="B40-ijms-18-01404">40</xref>]. JHDM1 is specific for H3K36me1/me2 demethylation, whereas JHDM3 uses H3K36 and H3K9 residues as substrates for the me2/me3-specific demethylation [<xref ref-type="bibr" rid="B41-ijms-18-01404">41</xref>]. Similarly, in addition to H3K36me2/me3-specific activity, RIOX1 preferentially demethylates H3K4me1/me3 residues [<xref ref-type="bibr" rid="B42-ijms-18-01404">42</xref>].</p>
<p>Histone H3 lysine 79 methylation (H3K79me) is associated with a diverse range of cellular processes including telomeric silencing, cellular development, cell-cycle checkpoint, DNA repair, and transcription regulation [<xref ref-type="bibr" rid="B43-ijms-18-01404">43</xref>]. However, only one H3K79-specific KMT is known, with no KDM for H3K79 demethylation reported to date. DOT1L is the sole enzyme that is responsible for all three forms of H3K79 methylation in humans [<xref ref-type="bibr" rid="B44-ijms-18-01404">44</xref>]. In addition, DOT1L is unique because it is the only non-SET domain containing methyltransferase, which has been identified to date [<xref ref-type="bibr" rid="B18-ijms-18-01404">18</xref>]. </p>
<p>Methylation on Histone H4 lysine 20 (H4K20me) displays various biological processes depending on its methylated levels. H4K20me1 is associated with transcriptional activation, appearing in the most highly transcribed group of genes with other core modifications at active promoters [<xref ref-type="bibr" rid="B45-ijms-18-01404">45</xref>]. H4K20me2 has distinct roles, such as marking points of replication origin and damage response in the DNA [<xref ref-type="bibr" rid="B46-ijms-18-01404">46</xref>,<xref ref-type="bibr" rid="B47-ijms-18-01404">47</xref>]. Conversely, H4K20me3 is associated with transcriptional repression at promoters and silencing of repetitive DNA and transposons [<xref ref-type="bibr" rid="B45-ijms-18-01404">45</xref>,<xref ref-type="bibr" rid="B48-ijms-18-01404">48</xref>]. H4K20me is catalyzed by three enzymes, with activities restricted to specific methylation states. KMT5A, the first identified H4K20 methyltransferase, is the only H4K20me1 enzyme [<xref ref-type="bibr" rid="B49-ijms-18-01404">49</xref>]. H4K20me1 can be further di- and tri-methylated by KMT5B and KMT5C [<xref ref-type="bibr" rid="B50-ijms-18-01404">50</xref>]. Similarly, several distinct demethylases are involved in the removal of specific H4K20me. PHF8 acts as a demethylase for H4K20me1 [<xref ref-type="bibr" rid="B51-ijms-18-01404">51</xref>]. Intriguingly, as previously described, PHF8 is the KDM that has additional activities towards H3K9me1 and H3K9me2 [<xref ref-type="bibr" rid="B8-ijms-18-01404">8</xref>]. In addition, LSD1n, an alternatively spliced form of KDM1A, demethylates H4K20me1 and H4K20me2 [<xref ref-type="bibr" rid="B52-ijms-18-01404">52</xref>], while PHF2 displays demethylase activity on H4K20me3 [<xref ref-type="bibr" rid="B53-ijms-18-01404">53</xref>].</p>
</sec>
<sec id="sec3-ijms-18-01404">
<title>3. Neurodevelopmental Disorders Related with Histone Lysine Methylations</title>
<sec id="sec3dot1-ijms-18-01404">
<title>3.1. H3K4 Methylation</title>
<sec id="sec3dot1dot1-ijms-18-01404">
<title>3.1.1. KMT2A and Wiedemann-Steiner Syndrome</title>
<p>Mutations in <italic>KMT2A</italic> were reported to be associated with Wiedemann-Steiner syndrome (WDSTS; OMIM 605130), an extremely rare neurodevelopmental condition accompanied by microcephaly, short stature, autism-like phenotype, and aggression [<xref ref-type="bibr" rid="B54-ijms-18-01404">54</xref>]. Interestingly, these abnormal brain functions were recapitulated in <italic>KMT2A</italic> heterozygous mutant mice, which displayed profound deficits in long-term contextual fear memory [<xref ref-type="bibr" rid="B55-ijms-18-01404">55</xref>,<xref ref-type="bibr" rid="B56-ijms-18-01404">56</xref>]. In particular, neuronal ablation of <italic>KMT2A</italic> in the postnatal forebrain and adult prefrontal cortex exhibited increased anxiety and robust cognitive deficits in mice. In the same study, the analyzing H3K4me3 level and the gene expression profiles in <italic>KMT2A</italic>-deficient cortical neurons revealed that the homeodomain transcription factor, MEIS2, was repressed in these mice. Moreover, <italic>MEIS2</italic> knockdown in prefrontal cortex phenocopied memory defects elicited by the deletion of <italic>KMT2A</italic> [<xref ref-type="bibr" rid="B57-ijms-18-01404">57</xref>], thus proposing a critical role of MEIS2 in the pathogenesis of WDSTS.</p>
</sec>
<sec id="sec3dot1dot2-ijms-18-01404">
<title>3.1.2. KMT2D and Kabuki Syndrome 1</title>
<p>The most well-studied neurodevelopmental disorder associated with dysregulated H3K4me is Kabuki syndrome 1 (KABUK1; OMIM 147920), which is a rare congenital syndrome characterized by a distinctive face (a reminiscent of the make-up of actors Kabuki, traditional Japanese music-drama) and mental retardation with additional features including autism, seizure, and microcephaly [<xref ref-type="bibr" rid="B58-ijms-18-01404">58</xref>]. Heterozygous mutations in <italic>KMT2D</italic> were found in more than 50% of patients with KABUK1, with the majority of mutations resulting in the premature termination of the protein product. In addition, mutations in <italic>KDM6A</italic>, an H3K27me demethylase gene, were also reported to contribute to less than 10% of this syndrome, and this type is referred as Kabuki syndrome 2 (KABUK2; OMIM 300867) [<xref ref-type="bibr" rid="B59-ijms-18-01404">59</xref>,<xref ref-type="bibr" rid="B60-ijms-18-01404">60</xref>,<xref ref-type="bibr" rid="B61-ijms-18-01404">61</xref>,<xref ref-type="bibr" rid="B62-ijms-18-01404">62</xref>]. Recently, Bögershausen et al. identified two mutations in <italic>RAP1A/B</italic>, which encode the Ras family small GTPases, in patients with KABUK1 by whole exome sequencing [<xref ref-type="bibr" rid="B61-ijms-18-01404">61</xref>]. The authors also demonstrated that mutant <italic>RAP1</italic> morphant phenocopied <italic>KDM6A</italic> and <italic>KMT2D</italic> mutants in zebrafish, and that the MEK/ERK pathway signaling was perturbed in <italic>RAP1</italic>- and <italic>KMT2D</italic>-defective cells. Interestingly, these phenotypes were rescued by treatment with an MEK inhibitor. On the other hands, the reduction in neurogenesis and hippocampal memory defects exhibited in a KABUK1 mouse model were ameliorated by the treatment with a histone deacetylase (HDAC) inhibitor, AR-42 [<xref ref-type="bibr" rid="B63-ijms-18-01404">63</xref>]. Furthermore, a ketogenic diet rescued hippocampal memory defects through the elevation of beta-hydroxybutyrate, an endogenous HDAC inhibitor, in the same mice model [<xref ref-type="bibr" rid="B64-ijms-18-01404">64</xref>]. Taken together, these results potentially provide diverse therapeutic directions to treat, or at least mitigate, the symptoms of KABUK1.</p>
</sec>
<sec id="sec3dot1dot3-ijms-18-01404">
<title>3.1.3. SETD1A and Schizophrenia</title>
<p>Extensive exome sequencing from over 200 patients with schizophrenia (SCZD; OMIM 181500) revealed two de novo mutations in <italic>SETD1A</italic>, which likely cause malfunction of SETD1A activity [<xref ref-type="bibr" rid="B65-ijms-18-01404">65</xref>]. Furthermore, a strong association between the loss-of-function mutation of <italic>SETD1A</italic> and SCZD was confirmed by analyzing the whole exome sequencing of over 4000 patients with SCZD [<xref ref-type="bibr" rid="B66-ijms-18-01404">66</xref>]. Interestingly, a recent bioinformatic analysis demonstrated that in addition to mutations in the protein coding region, mutations in the regulatory elements of <italic>SETD1A</italic> also contributed to the etiology of SCZD. De novo synonymous mutations within frontal cortex-derived DNase I-hypersensitive sites were enriched in SCZD, and <italic>SETD1A</italic> was identified as the highest statistical significant gene [<xref ref-type="bibr" rid="B67-ijms-18-01404">67</xref>].</p>
</sec>
<sec id="sec3dot1dot4-ijms-18-01404">
<title>3.1.4. H3K4me Demethylases and Neurodevelopmental Disorders</title>
<p>Given the intimate association between H3K4 methylation and neurodevelopment disorders, it is rational to assume that KDMs that are responsible for demethylation of H3K4me can be also mutated in neurodevelopmental disorders. Indeed, homozygous missense mutation in <italic>KDM5A</italic> has been reported in an individual with intellectual disability [<xref ref-type="bibr" rid="B68-ijms-18-01404">68</xref>]. Furthermore, <italic>KDM5C</italic>, another H3K4 demethylase coding gene, has been recurrently mutated in patients with mental retardation, X-linked, syndromic, Claes-Jensen type (MRXSCJ; OMIM 300534) [<xref ref-type="bibr" rid="B68-ijms-18-01404">68</xref>,<xref ref-type="bibr" rid="B69-ijms-18-01404">69</xref>,<xref ref-type="bibr" rid="B70-ijms-18-01404">70</xref>]. Intriguingly, <italic>KDM5C</italic> has been shown to be transcriptionally regulated by ARX, a homeobox transcription factor, which is frequently mutated in X-linked mental retardation and epilepsy [<xref ref-type="bibr" rid="B71-ijms-18-01404">71</xref>,<xref ref-type="bibr" rid="B72-ijms-18-01404">72</xref>,<xref ref-type="bibr" rid="B73-ijms-18-01404">73</xref>,<xref ref-type="bibr" rid="B74-ijms-18-01404">74</xref>]. Additionally, a missense mutation in amine oxidase domain of KDM1A has been reported in patients with mixed features of KABUK1 and KBG syndrome (KBGS; OMIM 148050), which are characterized by macrodontia, distinctive craniofacial findings, and intellectual disability [<xref ref-type="bibr" rid="B75-ijms-18-01404">75</xref>]. It is noteworthy that KDM1A catalyzes the demethylation of mono- and di-methylated H3K4, while other KDMs can demethylate H3K4me1/2/3 [<xref ref-type="bibr" rid="B76-ijms-18-01404">76</xref>]. </p>
</sec>
<sec id="sec3dot1dot5-ijms-18-01404">
<title>3.1.5. PHF21A and Potocki-Shaffer Syndrome</title>
<p>Besides H3K4me writers and erasers, PHF21A, an unmethylated H3K4 reader, was associated with a neurodevelopmental disorder. <italic>PHF21A</italic> was translocated in patients with Potocki-Shaffer syndrome (PSS; OMIM 601224), characterized by multiple exostoses, parietal foramina, intellectual disability, and craniofacial anomalies [<xref ref-type="bibr" rid="B77-ijms-18-01404">77</xref>,<xref ref-type="bibr" rid="B78-ijms-18-01404">78</xref>,<xref ref-type="bibr" rid="B79-ijms-18-01404">79</xref>]. This translocation commonly results in deletion of the PHD domain coding region of <italic>PHF21A</italic>, suggesting that dictation of unmethylated H3K4 is crucial for its functions. Accordingly, the deficiency of head development was observed in <italic>PHF21A</italic> morpholino-injected zebrafish, and this defect was rescued by injection of human <italic>PHF21A</italic> mRNA [<xref ref-type="bibr" rid="B78-ijms-18-01404">78</xref>]. In addition, PHF21A, in combination with KDM1A, is a key component of the BHC complex, which is involved in the repression of neuron-specific genes [<xref ref-type="bibr" rid="B80-ijms-18-01404">80</xref>]. Furthermore, <italic>SCN3A</italic>, a KDM1A target gene, was derepressed, and LSD1 occupancy at the <italic>SCN3A</italic> promoter was reduced in <italic>PHF21A</italic>-translocated lymphoblastoid cell lines [<xref ref-type="bibr" rid="B78-ijms-18-01404">78</xref>], hence proposing the idea that interplay between KDM1A and PHF21A is indispensable for normal brain development. </p>
</sec>
</sec>
<sec id="sec3dot2-ijms-18-01404">
<title>3.2. H3K9 Methylation</title>
<sec id="sec3dot2dot1-ijms-18-01404">
<title>3.2.1. EHMT1 and Kleefstra Syndrome</title>
<p>Mutations in <italic>EHMT1</italic>, a gene encoding H3K9 methyltransferase, have been associated with Kleefstra syndrome (KS; OMIM 610253) which is characterized by intellectual disability, childhood hypotonia, and distinctive facial features [<xref ref-type="bibr" rid="B81-ijms-18-01404">81</xref>,<xref ref-type="bibr" rid="B82-ijms-18-01404">82</xref>]. Previously, this syndrome was known as the 9q Subtelomeric Deletion syndrome, in which minimal critical deleted region comprises <italic>EHMT1</italic> [<xref ref-type="bibr" rid="B83-ijms-18-01404">83</xref>]. In agreement with the role of EHMT1 on neurodevelopment in human, both <italic>Drosophila EHMT</italic> mutants and <italic>EHMT1</italic> heterozygous knockout mice showed deficits in dendrite branching, learning, and memory [<xref ref-type="bibr" rid="B84-ijms-18-01404">84</xref>,<xref ref-type="bibr" rid="B85-ijms-18-01404">85</xref>]. Recent studies revealed the functions of EHMT1 in neurons, which may explain the phenotypes of patients and animal models of KS. A study measuring network and single cell activity in cortical cultures showed that EHMT1 is important for cortical neuronal network development [<xref ref-type="bibr" rid="B86-ijms-18-01404">86</xref>]. Additionally, EHMT1 mediates homeostatic synaptic scaling, which stabilizes the activity of neural networks by balancing excitation and inhibition [<xref ref-type="bibr" rid="B87-ijms-18-01404">87</xref>]. Interestingly, recent studies using exome sequencing revealed that the KS phenotypic spectrum was also linked to mutations in <italic>KMT2B</italic> and <italic>KMT2C</italic> [<xref ref-type="bibr" rid="B88-ijms-18-01404">88</xref>,<xref ref-type="bibr" rid="B89-ijms-18-01404">89</xref>], and these suggest that complicated epigenetic modules might underlie the pathogenesis of KS.</p>
</sec>
<sec id="sec3dot2dot2-ijms-18-01404">
<title>3.2.2. PHF8 and Siderius X-Linked Mental Retardation Syndrome </title>
<p>Siderius X-linked mental retardation syndrome (MRXSSD; OMIM 300263) is an X-linked intellectual disability condition; patients display mental retardation, a long face and broad nasal tip, and cleft lip and palate [<xref ref-type="bibr" rid="B90-ijms-18-01404">90</xref>,<xref ref-type="bibr" rid="B91-ijms-18-01404">91</xref>]. MRXSSD has been associated with mutations in <italic>PHF8</italic> [<xref ref-type="bibr" rid="B91-ijms-18-01404">91</xref>,<xref ref-type="bibr" rid="B92-ijms-18-01404">92</xref>,<xref ref-type="bibr" rid="B93-ijms-18-01404">93</xref>]. Interestingly, PHF8 has a histone lysine demethylase activity towards three different methylated lysines on histones, H3K9me1/2 and H4K20me1 [<xref ref-type="bibr" rid="B94-ijms-18-01404">94</xref>,<xref ref-type="bibr" rid="B95-ijms-18-01404">95</xref>,<xref ref-type="bibr" rid="B96-ijms-18-01404">96</xref>], and also functions as a trimethylated H3K4 reader [<xref ref-type="bibr" rid="B94-ijms-18-01404">94</xref>]. </p>
<p>Loss of a <italic>PHF8</italic> homolog in <italic>Caenorhabditis elegans</italic> resulted in axon guidance defects via the alteration of Hedgehog-like signaling [<xref ref-type="bibr" rid="B97-ijms-18-01404">97</xref>]. Furthermore, injection of zebrafish <italic>PHF8</italic> morpholino caused brain and craniofacial development defects [<xref ref-type="bibr" rid="B96-ijms-18-01404">96</xref>], thus suggested a critical role of histone methylation dynamics regulated by PHF8 in MRXSSD. However, surprisingly, a recent study showed that <italic>Phf8</italic>-deficient mice had no obvious developmental defects and cognitive impairment, while <italic>Phf8</italic>-deficient primary cells had reduced the proliferative potential [<xref ref-type="bibr" rid="B98-ijms-18-01404">98</xref>]. The results in mice indicated that MRXSSD is not simply caused by a single <italic>PFH8</italic> mutation, but rather by its combination with other genetic or environmental factors at the same time. The different phenotypes exhibited by some animal models and varying degrees of intellectual disability of human patients with MRXSSD can be attributed to the various targets and complex functions of PHF8.</p>
</sec>
</sec>
<sec id="sec3dot3-ijms-18-01404">
<title>3.3. H3K27 Methylation</title>
<sec>
<title>EZH2 and Weaver Syndrome</title>
<p>Weaver syndrome (WVS; OMIM 277590) is an autosomal dominant disorder characterized by overgrowth and intellectual disability [<xref ref-type="bibr" rid="B99-ijms-18-01404">99</xref>,<xref ref-type="bibr" rid="B100-ijms-18-01404">100</xref>,<xref ref-type="bibr" rid="B101-ijms-18-01404">101</xref>]. Exome sequencing studies identified <italic>EZH2</italic> as a causative gene of WVS [<xref ref-type="bibr" rid="B102-ijms-18-01404">102</xref>,<xref ref-type="bibr" rid="B103-ijms-18-01404">103</xref>]. EZH2 interacts with EED to form PRC2, which is an H3K27me3 methyltransferase complex [<xref ref-type="bibr" rid="B104-ijms-18-01404">104</xref>]. Interestingly, mutations in <italic>EED</italic> were found in individuals displaying symptoms similar to those of WVS [<xref ref-type="bibr" rid="B14-ijms-18-01404">14</xref>,<xref ref-type="bibr" rid="B105-ijms-18-01404">105</xref>], suggesting that the dysregulation of H3K27 methylation is responsible for these symptoms.</p>
<p>Several studies have shown that <italic>EZH2</italic> deficiencies in animal models induced abnormal neurogenesis in the cerebral cortex [<xref ref-type="bibr" rid="B106-ijms-18-01404">106</xref>], cerebellum [<xref ref-type="bibr" rid="B107-ijms-18-01404">107</xref>], and spinal cord [<xref ref-type="bibr" rid="B108-ijms-18-01404">108</xref>] during embryonic development. Moreover, <italic>EZH2</italic> is also implicated in adult hippocampal neurogenesis [<xref ref-type="bibr" rid="B109-ijms-18-01404">109</xref>]. The alteration of neurogenesis induced by <italic>EZH2</italic> deficiencies has been associated with various neurogenic processes, such as the reduction of neural progenitor cell proliferation [<xref ref-type="bibr" rid="B108-ijms-18-01404">108</xref>,<xref ref-type="bibr" rid="B109-ijms-18-01404">109</xref>,<xref ref-type="bibr" rid="B110-ijms-18-01404">110</xref>], cell fate change [<xref ref-type="bibr" rid="B106-ijms-18-01404">106</xref>,<xref ref-type="bibr" rid="B107-ijms-18-01404">107</xref>,<xref ref-type="bibr" rid="B111-ijms-18-01404">111</xref>,<xref ref-type="bibr" rid="B112-ijms-18-01404">112</xref>,<xref ref-type="bibr" rid="B113-ijms-18-01404">113</xref>], and neuronal migration [<xref ref-type="bibr" rid="B114-ijms-18-01404">114</xref>,<xref ref-type="bibr" rid="B115-ijms-18-01404">115</xref>,<xref ref-type="bibr" rid="B116-ijms-18-01404">116</xref>]. These results suggest that EZH2-induced H3K27 methylation plays an important role in various processes of neurodevelopment, dysfunction of which might be closely related to intellectual disability in patients with WVS.</p>
</sec>
</sec>
<sec id="sec3dot4-ijms-18-01404">
<title>3.4. H3K36 Methylation</title>
<sec id="sec3dot4dot1-ijms-18-01404">
<title>3.4.1. NSD1 Defects in Sotos Syndrome 1 and Beckwith-Wiedemann Syndrome</title>
<p>Recent studies demonstrated that disrupted levels or patterns of H3K36 methylation can cause a range of human diseases, including neurodevelopmental disorders. Among them, Sotos syndrome 1 (SOTOS1; OMIM 117550) represents an important human model system for studying the neurodevelopmental outcome of epigenetic dysregulation, which is caused by mutations in <italic>NSD1</italic> [<xref ref-type="bibr" rid="B117-ijms-18-01404">117</xref>]. SOTOS1 is an autosomal dominant disorder characterized by pre- and postnatal overgrowth, facial dysmorphism, macrocephaly, and non-progressive neurological delay [<xref ref-type="bibr" rid="B118-ijms-18-01404">118</xref>]. Interestingly, amplified genomic events of <italic>NSD1</italic> resulted in the opposite phenotypic outcome of SOTOS1, so that duplication in <italic>NSD1</italic> led to reversed clinical phenotypes of SOTOS1 with microcephaly, as well as delayed bone age, indicating the importance of proper <italic>NSD1</italic> expression during brain development [<xref ref-type="bibr" rid="B119-ijms-18-01404">119</xref>]. In addition, it was shown that neuroblastoma and glioma may occur in human in the absence of <italic>NSD1</italic> function [<xref ref-type="bibr" rid="B120-ijms-18-01404">120</xref>]. Although the MAPK/ERK pathway was mapped as a downstream signaling pathway of <italic>NSD1</italic>-related overgrowth of stature in SOTOS1 [<xref ref-type="bibr" rid="B121-ijms-18-01404">121</xref>], until recently, the molecular mechanisms how dysregulated NSD1 affects the mental retardation in SOTOS1 patients remains elusive. To date, two Sotos-like overgrowth syndromes called as Sotos syndrome 2 (SOTOS2; OMIM 614753) and 3 (SOTOS3; OMIM 617169) have been reported, which are caused by mutations in the <italic>NFIX</italic> and <italic>APC2</italic> genes, respectively [<xref ref-type="bibr" rid="B122-ijms-18-01404">122</xref>,<xref ref-type="bibr" rid="B123-ijms-18-01404">123</xref>]. Among the products of the two genes, APC2, a WNT signaling pathway regulator, has recently been suggested as a crucial target of NSD1, of which defects may cause the intellectual disability associated with SOTOS [<xref ref-type="bibr" rid="B123-ijms-18-01404">123</xref>]. In the mouse model system, <italic>Apc2</italic> deficiency caused impaired learning and memory abilities along with an abnormal head shape. In addition, <italic>Nsd1</italic> knockdown downregulated endogenous <italic>Apc2</italic> expression, and defective neuronal phenotypes caused by the knockdown were rescued by the forced expression of <italic>Apc2</italic>, suggesting that <italic>APC2</italic> may be a critical downstream gene of NSD1 in human neuronal cells.</p>
<p>Beckwith-Wiedemann syndrome (BWS; OMIM 130650) is another distinct overgrowth disorder with a broad clinical spectrum including hypoglycemia, ear creases/pits, cleft palate, and predisposition to embryonal tumors [<xref ref-type="bibr" rid="B124-ijms-18-01404">124</xref>]. Martinez-y-Martinez et al. documented that mental retardation was observed in 6 of the 39 BWS cases [<xref ref-type="bibr" rid="B125-ijms-18-01404">125</xref>]. It is well known that a major cause of BWS is the dysregulation of imprinted growth regulatory genes on chromosome 11p15 [<xref ref-type="bibr" rid="B126-ijms-18-01404">126</xref>]. Interestingly, mutations in the <italic>NSD1</italic> gene have been identified in 2 patients among 52 individuals clinically diagnosed with BWS, which suggests the involvement of <italic>NSD1</italic> in imprinting of the 11p15 region [<xref ref-type="bibr" rid="B127-ijms-18-01404">127</xref>]. </p>
</sec>
<sec id="sec3dot4dot2-ijms-18-01404">
<title>3.4.2. NSD2 and Wolf-Hirshhorn Syndrome</title>
<p><italic>NSD2</italic> is one of the major genes associated with Wolf-Hirshhorn syndrome (WHS; OMIM 194190), of which key features include severe growth and mental retardation, microcephaly, “Greek helmet” facies, and closure defects [<xref ref-type="bibr" rid="B128-ijms-18-01404">128</xref>]. Like patients with WHS, mice with <italic>Nsd2</italic> gene deletions were growth-retarded, showed midline, craniofacial, and ocular anomalies [<xref ref-type="bibr" rid="B129-ijms-18-01404">129</xref>]. However, these mice did not show any learning deficits [<xref ref-type="bibr" rid="B129-ijms-18-01404">129</xref>]. Although the downstream effectors of NSD2, such as RUNX2 and p300, which are known to play a role in bone development [<xref ref-type="bibr" rid="B130-ijms-18-01404">130</xref>], have been identified, the mechanism by which <italic>NSD2</italic> deficiency causes neurological disorders in patients with WHS is still unknown. </p>
</sec>
</sec>
<sec id="sec3dot5-ijms-18-01404">
<title>3.5. H4K20 Methylation</title>
<sec>
<title>Siderius X-Linked Syndromic Mental Retardation and Meier-Gorlin Syndrome 1</title>
<p>Thus far, two developmental diseases associated with dysregulated H4K20 methylation have been reported in human. As described above, one is MRXSSD (OMIM 300263) caused by mutations in <italic>PHF8</italic>, which encodes an eraser of H3K9 and H4K20 methylation. The other is Meier-Gorlin syndrome 1 (MGORS1; OMIM 224690) caused by homozygous or compound heterozygous mutation in the <italic>ORC1</italic> gene [<xref ref-type="bibr" rid="B131-ijms-18-01404">131</xref>], which encodes a specific reader of H4K20me2 [<xref ref-type="bibr" rid="B46-ijms-18-01404">46</xref>]. MGORS1 is a rare disorder characterized by severe intrauterine, postnatal growth retardation, and microcephaly [<xref ref-type="bibr" rid="B132-ijms-18-01404">132</xref>]. Interestingly, however, despite the presence of microcephaly, intellects of patients with MGORS1 are usually normal [<xref ref-type="bibr" rid="B133-ijms-18-01404">133</xref>].</p>
</sec>
</sec>
</sec>
<sec id="sec4-ijms-18-01404">
<title>4. Perspectives</title>
<p>As reviewed above, the pathogenesis of various neurodevelopmental disorders is closely associated with alterations in histone methylation status, which, in many cases, can be primarily attributed to loss-of-function mutations in related factors. Given that histone methylation status is meticulously regulated by the balance between two opposing enzymes (i.e., KMTs and KDMs), pharmaceutical inhibition of specific targets counteracting the loss-of-function mutations responsible for diseases can be a possible therapeutic option. Interestingly, a subset of currently available psychotherapeutic drugs, such as the atypical antipsychotic Clozapine, the mood-stabilizer Valproate, and the antidepressant Phenelzine are known to interfere with histone methylation in the brain [<xref ref-type="bibr" rid="B134-ijms-18-01404">134</xref>], although the relative contribution of this interference to their psychotherapeutic effects remains to be elucidated. In principle, an estimated 100 lysine and arginine residue-specific histone methyltransferases and demethylases [<xref ref-type="bibr" rid="B135-ijms-18-01404">135</xref>] can be reasonable therapeutic targets, since they are considered more specific than HDACs [<xref ref-type="bibr" rid="B134-ijms-18-01404">134</xref>]. Of note, histone methylation has been the most flourishing area of epigenetics research recently, and in line with this, huge efforts have been made to develop several potential therapeutic molecules, which specifically regulate histone methyltransferases and methylation reader proteins, particularly for cancer treatment [<xref ref-type="bibr" rid="B136-ijms-18-01404">136</xref>]. For example, selective inhibitors, such as EPZ005687, GSK126, and EI1, which target EZH2 of PRC2, were recently reported by three independent groups to inhibit proliferation of B-cell lymphomas harboring EZH2-activating mutations [<xref ref-type="bibr" rid="B137-ijms-18-01404">137</xref>,<xref ref-type="bibr" rid="B138-ijms-18-01404">138</xref>,<xref ref-type="bibr" rid="B139-ijms-18-01404">139</xref>]. In addition, tranylcypromine derivatives and polyaminoguanidine derivatives were designed and characterized to inhibit histone demethylases with potential anti-cancer activity [<xref ref-type="bibr" rid="B136-ijms-18-01404">136</xref>]. Several epigenetic compounds, such as ORY-1001 and GSK2879552, are currently undergoing clinical trials for cancer treatment. If they meet the required biosafety standards, they could potentially be strong candidates for treating neurodevelopmental disorders, by correcting the impaired histone methylation status. Moreover, a microRNA-based gene silencing strategy targeting a specific histone methyltransferase or demethylase can be an alternative therapeutic option to consider in this regard. Indeed, several studies have reported the important roles of miRNA in histone methylation and following transcriptional gene silencing in various model systems [<xref ref-type="bibr" rid="B140-ijms-18-01404">140</xref>,<xref ref-type="bibr" rid="B141-ijms-18-01404">141</xref>,<xref ref-type="bibr" rid="B142-ijms-18-01404">142</xref>]. Although further research is warranted, it will be interesting to establish whether these epigenetic compounds and/or microRNA-based specific gene silencing approaches have obvious therapeutic benefits for the patients with the neurodevelopmental disorders outlined in this review.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>This work was supported by the DGIST R&amp;D and MIREBraiN program, Basic Science Research Program through the ministry of science, ICT &amp; future planning of Korea (17-BD-0402, 17-BT-02, and 17-01-HRSS-02); the Development of Platform Technology for Innovative Medical Measurements Program from the Korea Research Institute of Standards and Science (KRISS-2017-GP2017-0020) (Sung Bae Lee); the Basic Science Research Program of the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (NRF-2014R1A1A2056768 and NRF-2017R1A2B4004241 Kyoung Sang Cho), and NRF-2014R1A1A3051462) (Im-Soon Lee); the Korea Health Technology Research &amp; Development Project, Ministry of Health &amp; Welfare, Republic of Korea (HI12C1472) (Kyoung Sang Cho); and KRIBB initiative program (Jeong-Hoon Kim). </p>
</ack>
<notes>
<title>Author Contributions</title>
<p>Sung Bae Lee and Kyoung Sang Cho designed the review; and Jeong-Hoon Kim, Jang Ho Lee, Im-Soon Lee, Sung Bae Lee and Kyoung Sang Cho wrote the manuscript. </p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest.</p>
</notes>
<glossary>
<title>Abbreviations</title>
<array orientation="portrait">
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">APC2</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Adenomatosis polyposis coli 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ARX</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Aristaless related homeobox</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ASH1L</td>
<td align="left" colspan="1" rowspan="1" valign="middle">ASH1 like histone lysine methyltransferase</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">BHC complex</td>
<td align="left" colspan="1" rowspan="1" valign="middle">BRAF35/histone deacetylase complex</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">BWS</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Beckwith-Wiedemann syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">DOT1L</td>
<td align="left" colspan="1" rowspan="1" valign="middle">DOT1 like histone lysine methyltransferase</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">EED</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Embryonic ectoderm development</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">EHMT1</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Euchromatic histone lysine methyltransferase 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">EHMT2</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Euchromatic histone lysine methyltransferase 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ERK</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Extracellular signal-regulated kinase</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ESC</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Embryonic stem cells</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">EZH1</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Enhancer of zeste 1 polycomb repressive complex 2 subunit</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">EZH2</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Enhancer of zeste 2 polycomb repressive complex 2 subunit</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">FAD</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Flavin adenosine dinucleotide</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">H3K4</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Histone H3 lysine 4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">H3K4me</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Methylation on histone H3 lysine 4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">H3K9</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Histone H3 lysine 9</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">H3K9me</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Methylation on histone H3 lysine 9</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">H3K27</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Histone H3 lysine 27</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">H3K27me</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Methylation on histone H3 lysine 27</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">H3K36</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Histone H3 lysine 36</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">H3K36me</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Methylation on histone H3 lysine 36</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">H3K79</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Histone H3 lysine 79</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">H3K79me</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Methylation on histone H3 lysine 79</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">H3R2</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Histone H3 arginine 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">H3R8</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Histone H3 arginine 8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">H3R17</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Histone H3 arginine 17</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">H3R26</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Histone H3 arginine 26</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">H4K20</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Histone H4 lysine 20</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">H4K20me</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Methylation on histone H4 lysine 20</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">H4R3</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Histone H4 arginine 3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">HDAC</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Histone deacetylase</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">HP1</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Heterochromatin protein 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">JHDM</td>
<td align="left" colspan="1" rowspan="1" valign="middle">JmjC-domain containing histone demethylases</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">JmjC</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Jumonji C</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">KABUK1</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Kabuki syndrome 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">KABUK2</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Kabuki syndrome 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">KBGS</td>
<td align="left" colspan="1" rowspan="1" valign="middle">KBG syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">KS</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Kleefstra syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">LSD1n</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Lysine-specific demethylase 1 variant</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">KDM</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Lysine demethylase</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">KMT</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Lysine methyl transferase</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">MAPK</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Mitogen-activated protein kinase</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">MEIS2</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Myeloid ecotropic viral integration site 1 homolog 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">MEK</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Mitogen-activated protein kinase kinase</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">MGORS1</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Meier-Gorlin syndrome 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">MRXSCJ</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Mental retardation, X-linked, syndromic, Claes-Jensen type</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">MRXSSD</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Siderius X-linked mental retardation syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">NFIX</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Nuclear factor I X</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">NSD1</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Nuclear receptor-binding SET domain protein 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">NSD2</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Nuclear receptor-binding SET domain protein 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">NSD3</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Nuclear receptor-binding SET domain protein 3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ORC1</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Origin recognition complex subunit 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">PHF2</td>
<td align="left" colspan="1" rowspan="1" valign="middle">PHD finger protein 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">PHF21A</td>
<td align="left" colspan="1" rowspan="1" valign="middle">PHD finger protein 21A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">PHF8</td>
<td align="left" colspan="1" rowspan="1" valign="middle">PHD finger protein 8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">PRC1</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Polycomb repressive complex 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">PRC2</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Polycomb repressive complex 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">PRDM</td>
<td align="left" colspan="1" rowspan="1" valign="middle">PR/SET domain family</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">PSS</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Potocki-Shaffer syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">RAP1A/B</td>
<td align="left" colspan="1" rowspan="1" valign="middle">RAS-related protein 1A/B</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">RIOX1</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Ribosomal oxygenase 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">RUNX2</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Runt related transcription factor 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">SCZD</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Schizophrenia</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">SCN3A</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Sodium voltage-gated channel alpha subunit 3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">SETD1A</td>
<td align="left" colspan="1" rowspan="1" valign="middle">SET domain containing 1A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">SETD1B</td>
<td align="left" colspan="1" rowspan="1" valign="middle">SET domain containing 1B</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">SETD2</td>
<td align="left" colspan="1" rowspan="1" valign="middle">SET domain containing 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">SETD3</td>
<td align="left" colspan="1" rowspan="1" valign="middle">SET domain containing 3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">SETDB1</td>
<td align="left" colspan="1" rowspan="1" valign="middle">SET domain bifurcated 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">SETMAR</td>
<td align="left" colspan="1" rowspan="1" valign="middle">SET domain and mariner transposase fusion gene</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">SMYD2</td>
<td align="left" colspan="1" rowspan="1" valign="middle">SET and MYND domain containing 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">SOTOS1</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Sotos syndrome 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">SOTOS2</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Sotos syndrome 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">SOTOS3</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Sotos syndrome 3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">SUV39H1</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Suppressor of variegation 3-9 homolog 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">SUV39H2</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Suppressor of variegation 3-9 homolog 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">UTY</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Ubiquitously transcribed tetratricopeptide repeat containing, Y-linked</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">WDSTS</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Wiedemann-Steiner syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">WHS</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Wolf-Hirshhorn syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">WVS</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Weaver syndrome</td>
</tr>
</tbody>
</array>
</glossary>
<ref-list>
<title>References</title>
<ref id="B1-ijms-18-01404">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jenuwein</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Allis</surname>
<given-names>C.D.</given-names>
</name>
</person-group>
<article-title>Translating the histone code</article-title>
<source/>Science
          <year>2001</year>
<volume>293</volume>
<fpage>1074</fpage>
<lpage>1080</lpage>
<pub-id pub-id-type="doi">10.1126/science.1063127</pub-id>
<pub-id pub-id-type="pmid">11498575</pub-id>
</element-citation>
</ref>
<ref id="B2-ijms-18-01404">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kouzarides</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Chromatin modifications and their function</article-title>
<source/>Cell
          <year>2007</year>
<volume>128</volume>
<fpage>693</fpage>
<lpage>705</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2007.02.005</pub-id>
<pub-id pub-id-type="pmid">17320507</pub-id>
</element-citation>
</ref>
<ref id="B3-ijms-18-01404">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>The diverse functions of histone lysine methylation</article-title>
<source/>Nat. Rev. Mol. Cell Biol.
          <year>2005</year>
<volume>6</volume>
<fpage>838</fpage>
<lpage>849</lpage>
<pub-id pub-id-type="doi">10.1038/nrm1761</pub-id>
<pub-id pub-id-type="pmid">16261189</pub-id>
</element-citation>
</ref>
<ref id="B4-ijms-18-01404">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greer</surname>
<given-names>E.L.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Histone methylation: A dynamic mark in health, disease and inheritance</article-title>
<source/>Nat. Rev. Genet.
          <year>2012</year>
<volume>13</volume>
<fpage>343</fpage>
<lpage>357</lpage>
<pub-id pub-id-type="doi">10.1038/nrg3173</pub-id>
<pub-id pub-id-type="pmid">22473383</pub-id>
</element-citation>
</ref>
<ref id="B5-ijms-18-01404">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berger</surname>
<given-names>S.L.</given-names>
</name>
</person-group>
<article-title>The complex language of chromatin regulation during transcription</article-title>
<source/>Nature
          <year>2007</year>
<volume>447</volume>
<fpage>407</fpage>
<lpage>412</lpage>
<pub-id pub-id-type="doi">10.1038/nature05915</pub-id>
<pub-id pub-id-type="pmid">17522673</pub-id>
</element-citation>
</ref>
<ref id="B6-ijms-18-01404">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Lorenzo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bedford</surname>
<given-names>M.T.</given-names>
</name>
</person-group>
<article-title>Histone arginine methylation</article-title>
<source/>FEBS Lett.
          <year>2011</year>
<volume>585</volume>
<fpage>2024</fpage>
<lpage>2031</lpage>
<pub-id pub-id-type="doi">10.1016/j.febslet.2010.11.010</pub-id>
<pub-id pub-id-type="pmid">21074527</pub-id>
</element-citation>
</ref>
<ref id="B7-ijms-18-01404">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fuchs</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Demidov</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Houben</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schubert</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Chromosomal histone modification patterns–from conservation to diversity</article-title>
<source/>Trends Plant Sci.
          <year>2006</year>
<volume>11</volume>
<fpage>199</fpage>
<lpage>208</lpage>
<pub-id pub-id-type="doi">10.1016/j.tplants.2006.02.008</pub-id>
<pub-id pub-id-type="pmid">16546438</pub-id>
</element-citation>
</ref>
<ref id="B8-ijms-18-01404">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hyun</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Writing, erasing and reading histone lysine methylations</article-title>
<source/>Exp. Mol. Med.
          <year>2017</year>
<volume>49</volume>
<fpage>e324</fpage>
<pub-id pub-id-type="doi">10.1038/emm.2017.11</pub-id>
<pub-id pub-id-type="pmid">28450737</pub-id>
</element-citation>
</ref>
<ref id="B9-ijms-18-01404">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bale</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Baram</surname>
<given-names>T.Z.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Insel</surname>
<given-names>T.R.</given-names>
</name>
<name>
<surname>McCarthy</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Nemeroff</surname>
<given-names>C.B.</given-names>
</name>
<name>
<surname>Reyes</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Simerly</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Susser</surname>
<given-names>E.S.</given-names>
</name>
</person-group>
<article-title>Early life programming and neurodevelopmental disorders</article-title>
<source/>Biol. Psychiatry
          <year>2010</year>
<volume>68</volume>
<fpage>314</fpage>
<lpage>319</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2010.05.028</pub-id>
<pub-id pub-id-type="pmid">20674602</pub-id>
</element-citation>
</ref>
<ref id="B10-ijms-18-01404">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Millan</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy</article-title>
<source/>Neuropharmacology
          <year>2013</year>
<volume>68</volume>
<fpage>2</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2012.11.015</pub-id>
<pub-id pub-id-type="pmid">23246909</pub-id>
</element-citation>
</ref>
<ref id="B11-ijms-18-01404">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilissen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hoischen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Brunner</surname>
<given-names>H.G.</given-names>
</name>
<name>
<surname>Veltman</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Unlocking Mendelian disease using exome sequencing</article-title>
<source/>Genome Biol.
          <year>2011</year>
<volume>12</volume>
<fpage>228</fpage>
<pub-id pub-id-type="doi">10.1186/gb-2011-12-9-228</pub-id>
<pub-id pub-id-type="pmid">21920049</pub-id>
</element-citation>
</ref>
<ref id="B12-ijms-18-01404">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ronan</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Crabtree</surname>
<given-names>G.R.</given-names>
</name>
</person-group>
<article-title>From neural development to cognition: Unexpected roles for chromatin</article-title>
<source/>Nat. Rev. Genet.
          <year>2013</year>
<volume>14</volume>
<fpage>347</fpage>
<lpage>359</lpage>
<pub-id pub-id-type="doi">10.1038/nrg3413</pub-id>
<pub-id pub-id-type="pmid">23568486</pub-id>
</element-citation>
</ref>
<ref id="B13-ijms-18-01404">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vissers</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Gilissen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Veltman</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Genetic studies in intellectual disability and related disorders</article-title>
<source/>Nat. Rev. Genet.
          <year>2016</year>
<volume>17</volume>
<fpage>9</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="doi">10.1038/nrg3999</pub-id>
<pub-id pub-id-type="pmid">26503795</pub-id>
</element-citation>
</ref>
<ref id="B14-ijms-18-01404">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tatton-Brown</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Loveday</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yost</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ramsay</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Zachariou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Elliott</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wylie</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ardissone</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rittinger</surname>
<given-names>O.</given-names>
</name>
</person-group>
<article-title>Mutations in epigenetic regulation genes are a major cause of overgrowth with intellectual disability</article-title>
<source/>Am. J. Hum. Genet.
          <year>2017</year>
<volume>100</volume>
<fpage>725</fpage>
<lpage>736</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2017.03.010</pub-id>
<pub-id pub-id-type="pmid">28475857</pub-id>
</element-citation>
</ref>
<ref id="B15-ijms-18-01404">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heintzman</surname>
<given-names>N.D.</given-names>
</name>
<name>
<surname>Stuart</surname>
<given-names>R.K.</given-names>
</name>
<name>
<surname>Hon</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ching</surname>
<given-names>C.W.</given-names>
</name>
<name>
<surname>Hawkins</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Barrera</surname>
<given-names>L.O.</given-names>
</name>
<name>
<surname>Van Calcar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ching</surname>
<given-names>K.A.</given-names>
</name>
</person-group>
<article-title>Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome</article-title>
<source/>Nat. Genet.
          <year>2007</year>
<volume>39</volume>
<fpage>311</fpage>
<lpage>318</lpage>
<pub-id pub-id-type="doi">10.1038/ng1966</pub-id>
<pub-id pub-id-type="pmid">17277777</pub-id>
</element-citation>
</ref>
<ref id="B16-ijms-18-01404">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heintzman</surname>
<given-names>N.D.</given-names>
</name>
<name>
<surname>Hon</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Hawkins</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Kheradpour</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Stark</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Harp</surname>
<given-names>L.F.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>L.K.</given-names>
</name>
<name>
<surname>Stuart</surname>
<given-names>R.K.</given-names>
</name>
<name>
<surname>Ching</surname>
<given-names>C.W.</given-names>
</name>
</person-group>
<article-title>Histone modifications at human enhancers reflect global cell-type-specific gene expression</article-title>
<source/>Nature
          <year>2009</year>
<volume>459</volume>
<fpage>108</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="doi">10.1038/nature07829</pub-id>
<pub-id pub-id-type="pmid">19295514</pub-id>
</element-citation>
</ref>
<ref id="B17-ijms-18-01404">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allis</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Cote</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dent</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jenuwien</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kouzarides</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Pillus</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Reinberg</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shiekhattar</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>New nomenclature for chromatin-modifying enzymes</article-title>
<source/>Cell
          <year>2007</year>
<volume>131</volume>
<fpage>633</fpage>
<lpage>636</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2007.10.039</pub-id>
<pub-id pub-id-type="pmid">18022353</pub-id>
</element-citation>
</ref>
<ref id="B18-ijms-18-01404">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shilatifard</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Chromatin modifications by methylation and ubiquitination: Implications in the regulation of gene expression</article-title>
<source/>Annu. Rev. Biochem.
          <year>2006</year>
<volume>75</volume>
<fpage>243</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.biochem.75.103004.142422</pub-id>
<pub-id pub-id-type="pmid">16756492</pub-id>
</element-citation>
</ref>
<ref id="B19-ijms-18-01404">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rao</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Dou</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Hijacked in cancer: The KMT2 (MLL) family of methyltransferases</article-title>
<source/>Nat. Rev. Cancer
          <year>2015</year>
<volume>15</volume>
<fpage>334</fpage>
<lpage>346</lpage>
<pub-id pub-id-type="doi">10.1038/nrc3929</pub-id>
<pub-id pub-id-type="pmid">25998713</pub-id>
</element-citation>
</ref>
<ref id="B20-ijms-18-01404">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wagner</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Carpenter</surname>
<given-names>P.B.</given-names>
</name>
</person-group>
<article-title>Understanding the language of Lys36 methylation at histone H3</article-title>
<source/>Nat. Rev. Mol. Cell Biol.
          <year>2012</year>
<volume>13</volume>
<fpage>115</fpage>
<lpage>126</lpage>
<pub-id pub-id-type="doi">10.1038/nrm3274</pub-id>
<pub-id pub-id-type="pmid">22266761</pub-id>
</element-citation>
</ref>
<ref id="B21-ijms-18-01404">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bannister</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Zegerman</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Partridge</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Miska</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>J.O.</given-names>
</name>
<name>
<surname>Allshire</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Kouzarides</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain</article-title>
<source/>Nature
          <year>2001</year>
<volume>410</volume>
<fpage>120</fpage>
<lpage>124</lpage>
<pub-id pub-id-type="doi">10.1038/35065138</pub-id>
<pub-id pub-id-type="pmid">11242054</pub-id>
</element-citation>
</ref>
<ref id="B22-ijms-18-01404">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lachner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>O’carroll</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rea</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mechtler</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Jenuwein</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins</article-title>
<source/>Nature
          <year>2001</year>
<volume>410</volume>
<fpage>116</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="doi">10.1038/35065132</pub-id>
<pub-id pub-id-type="pmid">11242053</pub-id>
</element-citation>
</ref>
<ref id="B23-ijms-18-01404">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakayama</surname>
<given-names>J.-I.</given-names>
</name>
<name>
<surname>Rice</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Strahl</surname>
<given-names>B.D.</given-names>
</name>
<name>
<surname>Allis</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Grewal</surname>
<given-names>S.I.</given-names>
</name>
</person-group>
<article-title>Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly</article-title>
<source/>Science
          <year>2001</year>
<volume>292</volume>
<fpage>110</fpage>
<lpage>113</lpage>
<pub-id pub-id-type="doi">10.1126/science.1060118</pub-id>
<pub-id pub-id-type="pmid">11283354</pub-id>
</element-citation>
</ref>
<ref id="B24-ijms-18-01404">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grewal</surname>
<given-names>S.I.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Heterochromatin revisited</article-title>
<source/>Nat. Rev. Genet.
          <year>2007</year>
<volume>8</volume>
<fpage>35</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="doi">10.1038/nrg2008</pub-id>
<pub-id pub-id-type="pmid">17173056</pub-id>
</element-citation>
</ref>
<ref id="B25-ijms-18-01404">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schultz</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Ayyanathan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Negorev</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Maul</surname>
<given-names>G.G.</given-names>
</name>
<name>
<surname>Rauscher</surname>
<given-names>F.J.</given-names>
</name>
</person-group>
<article-title>SETDB1: A novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins</article-title>
<source/>Genes Dev.
          <year>2002</year>
<volume>16</volume>
<fpage>919</fpage>
<lpage>932</lpage>
<pub-id pub-id-type="doi">10.1101/gad.973302</pub-id>
<pub-id pub-id-type="pmid">11959841</pub-id>
</element-citation>
</ref>
<ref id="B26-ijms-18-01404">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Metzger</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wissmann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Müller</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Günther</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Buettner</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Schüle</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription</article-title>
<source/>Nature
          <year>2005</year>
<volume>437</volume>
<fpage>436</fpage>
<lpage>439</lpage>
<pub-id pub-id-type="doi">10.1038/nature04020</pub-id>
<pub-id pub-id-type="pmid">16079795</pub-id>
</element-citation>
</ref>
<ref id="B27-ijms-18-01404">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Ju</surname>
<given-names>U.I.</given-names>
</name>
<name>
<surname>Seok</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Z.H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.H.</given-names>
</name>
</person-group>
<article-title>Plant homeodomain finger protein 2 promotes bone formation by demethylating and activating Runx2 for osteoblast differentiation</article-title>
<source/>Cell Res.
          <year>2014</year>
<volume>24</volume>
<fpage>1231</fpage>
<lpage>1249</lpage>
<pub-id pub-id-type="doi">10.1038/cr.2014.127</pub-id>
<pub-id pub-id-type="pmid">25257467</pub-id>
</element-citation>
</ref>
<ref id="B28-ijms-18-01404">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plath</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mlynarczyk-Evans</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Worringer</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cecile</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Otte</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Panning</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Role of histone H3 lysine 27 methylation in X inactivation</article-title>
<source/>Science
          <year>2003</year>
<volume>300</volume>
<fpage>131</fpage>
<lpage>135</lpage>
<pub-id pub-id-type="doi">10.1126/science.1084274</pub-id>
<pub-id pub-id-type="pmid">12649488</pub-id>
</element-citation>
</ref>
<ref id="B29-ijms-18-01404">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiles</surname>
<given-names>E.T.</given-names>
</name>
<name>
<surname>Selker</surname>
<given-names>E.U.</given-names>
</name>
</person-group>
<article-title>H3K27 methylation: A promiscuous repressive chromatin mark</article-title>
<source/>Curr. Opin. Genet. Dev.
          <year>2017</year>
<volume>43</volume>
<fpage>31</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="doi">10.1016/j.gde.2016.11.001</pub-id>
<pub-id pub-id-type="pmid">27940208</pub-id>
</element-citation>
</ref>
<ref id="B30-ijms-18-01404">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boyer</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Plath</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zeitlinger</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Brambrink</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Medeiros</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>T.I.</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Wernig</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tajonar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ray</surname>
<given-names>M.K.</given-names>
</name>
</person-group>
<article-title>Polycomb complexes repress developmental regulators in murine embryonic stem cells</article-title>
<source/>Nature
          <year>2006</year>
<volume>441</volume>
<fpage>349</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="doi">10.1038/nature04733</pub-id>
<pub-id pub-id-type="pmid">16625203</pub-id>
</element-citation>
</ref>
<ref id="B31-ijms-18-01404">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>T.I.</given-names>
</name>
<name>
<surname>Jenner</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Boyer</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Guenther</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Chevalier</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Johnstone</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Isono</surname>
<given-names>K.-I.</given-names>
</name>
</person-group>
<article-title>Control of developmental regulators by Polycomb in human embryonic stem cells</article-title>
<source/>Cell
          <year>2006</year>
<volume>125</volume>
<fpage>301</fpage>
<lpage>313</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2006.02.043</pub-id>
<pub-id pub-id-type="pmid">16630818</pub-id>
</element-citation>
</ref>
<ref id="B32-ijms-18-01404">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harikumar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Meshorer</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Chromatin remodeling and bivalent histone modifications in embryonic stem cells</article-title>
<source/>EMBO Rep.
          <year>2015</year>
<volume>16</volume>
<fpage>1609</fpage>
<lpage>1619</lpage>
<pub-id pub-id-type="doi">10.15252/embr.201541011</pub-id>
<pub-id pub-id-type="pmid">26553936</pub-id>
</element-citation>
</ref>
<ref id="B33-ijms-18-01404">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Margueron</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Reinberg</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>The Polycomb complex PRC2 and its mark in life</article-title>
<source/>Nature
          <year>2011</year>
<volume>469</volume>
<fpage>343</fpage>
<lpage>349</lpage>
<pub-id pub-id-type="doi">10.1038/nature09784</pub-id>
<pub-id pub-id-type="pmid">21248841</pub-id>
</element-citation>
</ref>
<ref id="B34-ijms-18-01404">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kizer</surname>
<given-names>K.O.</given-names>
</name>
<name>
<surname>Phatnani</surname>
<given-names>H.P.</given-names>
</name>
<name>
<surname>Shibata</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Greenleaf</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Strahl</surname>
<given-names>B.D.</given-names>
</name>
</person-group>
<article-title>A novel domain in Set2 mediates RNA polymerase II interaction and couples histone H3K36 methylation with transcript elongation</article-title>
<source/>Mol. Cell. Biol.
          <year>2005</year>
<volume>25</volume>
<fpage>3305</fpage>
<lpage>3316</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.25.8.3305-3316.2005</pub-id>
<pub-id pub-id-type="pmid">15798214</pub-id>
</element-citation>
</ref>
<ref id="B35-ijms-18-01404">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fong</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Erickson</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bentley</surname>
<given-names>D.L.</given-names>
</name>
</person-group>
<article-title>Pre-mRNA splicing is a determinant of histone H3K36 methylation</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2011</year>
<volume>108</volume>
<fpage>13564</fpage>
<lpage>13569</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1109475108</pub-id>
<pub-id pub-id-type="pmid">21807997</pub-id>
</element-citation>
</ref>
<ref id="B36-ijms-18-01404">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bell</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Conrad</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kind</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wirbelauer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Akhtar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schübeler</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Transcription-coupled methylation of histone H3 at lysine 36 regulates dosage compensation by enhancing recruitment of the MSL complex in <italic>Drosophila melanogaster</italic></article-title>
<source/>Mol. Cell. Biol.
          <year>2008</year>
<volume>28</volume>
<fpage>3401</fpage>
<lpage>3409</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.00006-08</pub-id>
<pub-id pub-id-type="pmid">18347056</pub-id>
</element-citation>
</ref>
<ref id="B37-ijms-18-01404">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fnu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>De Haro</surname>
<given-names>L.P.</given-names>
</name>
<name>
<surname>Brenneman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wray</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shaheen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Radhakrishnan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S.-H.</given-names>
</name>
<name>
<surname>Nickoloff</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Hromas</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Methylation of histone H3 lysine 36 enhances DNA repair by nonhomologous end-joining</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2011</year>
<volume>108</volume>
<fpage>540</fpage>
<lpage>545</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1013571108</pub-id>
<pub-id pub-id-type="pmid">21187428</pub-id>
</element-citation>
</ref>
<ref id="B38-ijms-18-01404">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strahl</surname>
<given-names>B.D.</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Briggs</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Z.-W.</given-names>
</name>
<name>
<surname>Bone</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Caldwell</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Mollah</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Shabanowitz</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hunt</surname>
<given-names>D.F.</given-names>
</name>
</person-group>
<article-title>Set2 is a nucleosomal histone H3-selective methyltransferase that mediates transcriptional repression</article-title>
<source/>Mol. Cell. Biol.
          <year>2002</year>
<volume>22</volume>
<fpage>1298</fpage>
<lpage>1306</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.22.5.1298-1306.2002</pub-id>
<pub-id pub-id-type="pmid">11839797</pub-id>
</element-citation>
</ref>
<ref id="B39-ijms-18-01404">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edmunds</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Mahadevan</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Clayton</surname>
<given-names>A.L.</given-names>
</name>
</person-group>
<article-title>Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation</article-title>
<source/>EMBO J.
          <year>2008</year>
<volume>27</volume>
<fpage>406</fpage>
<lpage>420</lpage>
<pub-id pub-id-type="doi">10.1038/sj.emboj.7601967</pub-id>
<pub-id pub-id-type="pmid">18157086</pub-id>
</element-citation>
</ref>
<ref id="B40-ijms-18-01404">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cloos</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Christensen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Agger</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Helin</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Erasing the methyl mark: Histone demethylases at the center of cellular differentiation and disease</article-title>
<source/>Genes Dev.
          <year>2008</year>
<volume>22</volume>
<fpage>1115</fpage>
<lpage>1140</lpage>
<pub-id pub-id-type="doi">10.1101/gad.1652908</pub-id>
<pub-id pub-id-type="pmid">18451103</pub-id>
</element-citation>
</ref>
<ref id="B41-ijms-18-01404">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>G.-M.</given-names>
</name>
</person-group>
<article-title>Decoding the histone code: Role of H3K36me3 in mismatch repair and implications for cancer susceptibility and therapy</article-title>
<source/>Cancer Res.
          <year>2013</year>
<volume>73</volume>
<fpage>6379</fpage>
<lpage>6383</lpage>
<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-13-1870</pub-id>
<pub-id pub-id-type="pmid">24145353</pub-id>
</element-citation>
</ref>
<ref id="B42-ijms-18-01404">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sinha</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Yasuda</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Coombes</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Dent</surname>
<given-names>S.Y.</given-names>
</name>
<name>
<surname>De Crombrugghe</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Regulation of the osteoblast-specific transcription factor Osterix by NO66, a Jumonji family histone demethylase</article-title>
<source/>EMBO J.
          <year>2010</year>
<volume>29</volume>
<fpage>68</fpage>
<lpage>79</lpage>
<pub-id pub-id-type="doi">10.1038/emboj.2009.332</pub-id>
<pub-id pub-id-type="pmid">19927124</pub-id>
</element-citation>
</ref>
<ref id="B43-ijms-18-01404">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farooq</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Banday</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pandita</surname>
<given-names>T.K.</given-names>
</name>
<name>
<surname>Altaf</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The many faces of histone H3K79 methylation</article-title>
<source/>Mutat. Res. Rev. Mutat. Res.
          <year>2016</year>
<volume>768</volume>
<fpage>46</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.1016/j.mrrev.2016.03.005</pub-id>
<pub-id pub-id-type="pmid">27234562</pub-id>
</element-citation>
</ref>
<ref id="B44-ijms-18-01404">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Leeuwen</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Gafken</surname>
<given-names>P.R.</given-names>
</name>
<name>
<surname>Gottschling</surname>
<given-names>D.E.</given-names>
</name>
</person-group>
<article-title>Dot1p modulates silencing in yeast by methylation of the nucleosome core</article-title>
<source/>Cell
          <year>2002</year>
<volume>109</volume>
<fpage>745</fpage>
<lpage>756</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(02)00759-6</pub-id>
<pub-id pub-id-type="pmid">12086673</pub-id>
</element-citation>
</ref>
<ref id="B45-ijms-18-01404">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Schones</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Barski</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cuddapah</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Roh</surname>
<given-names>T.-Y.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.Q.</given-names>
</name>
</person-group>
<article-title>Combinatorial patterns of histone acetylations and methylations in the human genome</article-title>
<source/>Nat. Genet.
          <year>2008</year>
<volume>40</volume>
<fpage>897</fpage>
<lpage>903</lpage>
<pub-id pub-id-type="doi">10.1038/ng.154</pub-id>
<pub-id pub-id-type="pmid">18552846</pub-id>
</element-citation>
</ref>
<ref id="B46-ijms-18-01404">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuo</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ishibe-Murakami</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yamazoe</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Gozani</surname>
<given-names>O.</given-names>
</name>
</person-group>
<article-title>The BAH domain of ORC1 links H4K20me2 to DNA replication licensing and Meier-Gorlin syndrome</article-title>
<source/>Nature
          <year>2012</year>
<volume>484</volume>
<fpage>115</fpage>
<lpage>119</lpage>
<pub-id pub-id-type="doi">10.1038/nature10956</pub-id>
<pub-id pub-id-type="pmid">22398447</pub-id>
</element-citation>
</ref>
<ref id="B47-ijms-18-01404">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Botuyan</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.-E.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mer</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Structural basis for the methylation state-specific recognition of histone H4K20 by 53BP1 and Crb2 in DNA repair</article-title>
<source/>Cell
          <year>2006</year>
<volume>127</volume>
<fpage>1361</fpage>
<lpage>1373</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2006.10.043</pub-id>
<pub-id pub-id-type="pmid">17190600</pub-id>
</element-citation>
</ref>
<ref id="B48-ijms-18-01404">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jørgensen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schotta</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sørensen</surname>
<given-names>C.S.</given-names>
</name>
</person-group>
<article-title>Histone H4 lysine 20 methylation: Key player in epigenetic regulation of genomic integrity</article-title>
<source/>Nucleic Acids Res.
          <year>2013</year>
<volume>41</volume>
<fpage>2797</fpage>
<lpage>2806</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkt012</pub-id>
<pub-id pub-id-type="pmid">23345616</pub-id>
</element-citation>
</ref>
<ref id="B49-ijms-18-01404">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishioka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Rice</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Sarma</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Erdjument-Bromage</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Werner</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chuikov</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Valenzuela</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tempst</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Steward</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin</article-title>
<source/>Mol. Cell
          <year>2002</year>
<volume>9</volume>
<fpage>1201</fpage>
<lpage>1213</lpage>
<pub-id pub-id-type="doi">10.1016/S1097-2765(02)00548-8</pub-id>
<pub-id pub-id-type="pmid">12086618</pub-id>
</element-citation>
</ref>
<ref id="B50-ijms-18-01404">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Pesavento</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Starnes</surname>
<given-names>T.W.</given-names>
</name>
<name>
<surname>Cryderman</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Wallrath</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>Kelleher</surname>
<given-names>N.L.</given-names>
</name>
<name>
<surname>Mizzen</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Preferential dimethylation of histone H4 lysine 20 by Suv4–20</article-title>
<source/>J. Biol. Chem.
          <year>2008</year>
<volume>283</volume>
<fpage>12085</fpage>
<lpage>12092</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M707974200</pub-id>
<pub-id pub-id-type="pmid">18296440</pub-id>
</element-citation>
</ref>
<ref id="B51-ijms-18-01404">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Tanasa</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Tyurina</surname>
<given-names>O.V.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>T.Y.</given-names>
</name>
<name>
<surname>Gassmann</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.T.</given-names>
</name>
<name>
<surname>Ohgi</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Benner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Garcia-Bassets</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Aggarwal</surname>
<given-names>A.K.</given-names>
</name>
</person-group>
<article-title>PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression</article-title>
<source/>Nature
          <year>2010</year>
<volume>466</volume>
<fpage>508</fpage>
<lpage>512</lpage>
<pub-id pub-id-type="doi">10.1038/nature09272</pub-id>
<pub-id pub-id-type="pmid">20622854</pub-id>
</element-citation>
</ref>
<ref id="B52-ijms-18-01404">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Telese</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Basnet</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Merkurjev</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>LSD1n is an H4K20 demethylase regulating memory formation via transcriptional elongation control</article-title>
<source/>Nat. Neurosci.
          <year>2015</year>
<volume>18</volume>
<fpage>1256</fpage>
<lpage>1264</lpage>
<pub-id pub-id-type="doi">10.1038/nn.4069</pub-id>
<pub-id pub-id-type="pmid">26214369</pub-id>
</element-citation>
</ref>
<ref id="B53-ijms-18-01404">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stender</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Pascual</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kaikkonen</surname>
<given-names>M.U.</given-names>
</name>
<name>
<surname>Do</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Spann</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Boutros</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Perrimon</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Glass</surname>
<given-names>C.K.</given-names>
</name>
</person-group>
<article-title>Control of proinflammatory gene programs by regulated trimethylation and demethylation of histone H4K20</article-title>
<source/>Mol. Cell
          <year>2012</year>
<volume>48</volume>
<fpage>28</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="doi">10.1016/j.molcel.2012.07.020</pub-id>
<pub-id pub-id-type="pmid">22921934</pub-id>
</element-citation>
</ref>
<ref id="B54-ijms-18-01404">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strom</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Lozano</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dorrani</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>O’Lague</surname>
<given-names>P.F.</given-names>
</name>
<name>
<surname>Mans</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Deignan</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Vilain</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>S.F.</given-names>
</name>
</person-group>
<article-title><italic>De Novo</italic> variants in the <italic>KMT2A</italic> (<italic>MLL</italic>) gene causing atypical Wiedemann-Steiner syndrome in two unrelated individuals identified by clinical exome sequencing</article-title>
<source/>BMC Med. Genet.
          <year>2014</year>
<volume>15</volume>
<elocation-id>49</elocation-id>
<pub-id pub-id-type="doi">10.1186/1471-2350-15-49</pub-id>
<pub-id pub-id-type="pmid">24886118</pub-id>
</element-citation>
</ref>
<ref id="B55-ijms-18-01404">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.Y.</given-names>
</name>
<name>
<surname>Artis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Molfese</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Schumacher</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sweatt</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Paylor</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Lubin</surname>
<given-names>F.D.</given-names>
</name>
</person-group>
<article-title>Histone methylation regulates memory formation</article-title>
<source/>J. Neurosci.
          <year>2010</year>
<volume>30</volume>
<fpage>3589</fpage>
<lpage>3599</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3732-09.2010</pub-id>
<pub-id pub-id-type="pmid">20219993</pub-id>
</element-citation>
</ref>
<ref id="B56-ijms-18-01404">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>S.Y.</given-names>
</name>
<name>
<surname>Levenson</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Korsmeyer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sweatt</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Schumacher</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Developmental regulation of Eed complex composition governs a switch in global histone modification in brain</article-title>
<source/>J. Biol. Chem.
          <year>2007</year>
<volume>282</volume>
<fpage>9962</fpage>
<lpage>9972</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M608722200</pub-id>
<pub-id pub-id-type="pmid">17259173</pub-id>
</element-citation>
</ref>
<ref id="B57-ijms-18-01404">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jakovcevski</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>E.Y.</given-names>
</name>
<name>
<surname>Dincer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Javidfar</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Peter</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Neuronal Kmt2a/Mll1 histone methyltransferase is essential for prefrontal synaptic plasticity and working memory</article-title>
<source/>J. Neurosci.
          <year>2015</year>
<volume>35</volume>
<fpage>5097</fpage>
<lpage>5108</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3004-14.2015</pub-id>
<pub-id pub-id-type="pmid">25834037</pub-id>
</element-citation>
</ref>
<ref id="B58-ijms-18-01404">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niikawa</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Matsuura</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fukushima</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ohsawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kajii</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Kabuki make-up syndrome: A syndrome of mental retardation, unusual facies, large and protruding ears, and postnatal growth deficiency</article-title>
<source/>J. Pediatr.
          <year>1981</year>
<volume>99</volume>
<fpage>565</fpage>
<lpage>569</lpage>
<pub-id pub-id-type="doi">10.1016/S0022-3476(81)80255-7</pub-id>
<pub-id pub-id-type="pmid">7277096</pub-id>
</element-citation>
</ref>
<ref id="B59-ijms-18-01404">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Bigham</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Buckingham</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Hannibal</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>McMillin</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Gildersleeve</surname>
<given-names>H.I.</given-names>
</name>
<name>
<surname>Beck</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Tabor</surname>
<given-names>H.K.</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Mefford</surname>
<given-names>H.C.</given-names>
</name>
</person-group>
<article-title>Exome sequencing identifies <italic>MLL2</italic> mutations as a cause of Kabuki syndrome</article-title>
<source/>Nat. Genet.
          <year>2010</year>
<volume>42</volume>
<fpage>790</fpage>
<lpage>793</lpage>
<pub-id pub-id-type="doi">10.1038/ng.646</pub-id>
<pub-id pub-id-type="pmid">20711175</pub-id>
</element-citation>
</ref>
<ref id="B60-ijms-18-01404">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paulussen</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Stegmann</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Blok</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Tserpelis</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Posma-Velter</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Detisch</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Smeets</surname>
<given-names>E.E.</given-names>
</name>
<name>
<surname>Wagemans</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schrander</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>van den Boogaard</surname>
<given-names>M.J.H.</given-names>
</name>
</person-group>
<article-title><italic>MLL2</italic> mutation spectrum in 45 patients with Kabuki syndrome</article-title>
<source/>Hum. Mutat.
          <year>2011</year>
<volume>32</volume>
<fpage>E2018</fpage>
<lpage>E2025</lpage>
<pub-id pub-id-type="doi">10.1002/humu.21416</pub-id>
<pub-id pub-id-type="pmid">21280141</pub-id>
</element-citation>
</ref>
<ref id="B61-ijms-18-01404">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bögershausen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wollnik</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Unmasking Kabuki syndrome</article-title>
<source/>Clin. Genet.
          <year>2013</year>
<volume>83</volume>
<fpage>201</fpage>
<lpage>211</lpage>
<pub-id pub-id-type="doi">10.1111/cge.12051</pub-id>
<pub-id pub-id-type="pmid">23131014</pub-id>
</element-citation>
</ref>
<ref id="B62-ijms-18-01404">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lederer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Grisart</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Digilio</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Benoit</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Crespin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ghariani</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Maystadt</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Dallapiccola</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Verellen-Dumoulin</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with Kabuki syndrome</article-title>
<source/>Am. J. Hum. Genet.
          <year>2012</year>
<volume>90</volume>
<fpage>119</fpage>
<lpage>124</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2011.11.021</pub-id>
<pub-id pub-id-type="pmid">22197486</pub-id>
</element-citation>
</ref>
<ref id="B63-ijms-18-01404">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benjamin</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Pilarowski</surname>
<given-names>G.O.</given-names>
</name>
<name>
<surname>Carosso</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Huso</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Goff</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Vernon</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Bjornsson</surname>
<given-names>H.T.</given-names>
</name>
</person-group>
<article-title>A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2017</year>
<volume>114</volume>
<fpage>125</fpage>
<lpage>130</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1611431114</pub-id>
<pub-id pub-id-type="pmid">27999180</pub-id>
</element-citation>
</ref>
<ref id="B64-ijms-18-01404">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bjornsson</surname>
<given-names>H.T.</given-names>
</name>
<name>
<surname>Benjamin</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Weissman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gerber</surname>
<given-names>E.E.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.-C.</given-names>
</name>
<name>
<surname>Vaurio</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Potter</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Dietz</surname>
<given-names>H.C.</given-names>
</name>
</person-group>
<article-title>Histone deacetylase inhibition rescues structural and functional brain deficits in a mouse model of Kabuki syndrome</article-title>
<source/>Sci. Transl. Med.
          <year>2014</year>
<volume>6</volume>
<fpage>256ra135</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3009278</pub-id>
<pub-id pub-id-type="pmid">25273096</pub-id>
</element-citation>
</ref>
<ref id="B65-ijms-18-01404">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takata</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ionita-Laza</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Roos</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Gogos</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Karayiorgou</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Loss-of-function variants in schizophrenia risk and <italic>SETD1A</italic> as a candidate susceptibility gene</article-title>
<source/>Neuron
          <year>2014</year>
<volume>82</volume>
<fpage>773</fpage>
<lpage>780</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2014.04.043</pub-id>
<pub-id pub-id-type="pmid">24853937</pub-id>
</element-citation>
</ref>
<ref id="B66-ijms-18-01404">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kurki</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Curtis</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Purcell</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Crooks</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>McRae</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Suvisaari</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chheda</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Blackwood</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Breen</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Rare loss-of-function variants in <italic>SETD1A</italic> are associated with schizophrenia and developmental disorders</article-title>
<source/>Nat. Neurosci.
          <year>2016</year>
<volume>19</volume>
<fpage>571</fpage>
<lpage>577</lpage>
<pub-id pub-id-type="doi">10.1038/nn.4267</pub-id>
<pub-id pub-id-type="pmid">26974950</pub-id>
</element-citation>
</ref>
<ref id="B67-ijms-18-01404">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takata</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ionita-Laza</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Gogos</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Karayiorgou</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title><italic>De novo</italic> synonymous mutations in regulatory elements contribute to the genetic etiology of autism and schizophrenia</article-title>
<source/>Neuron
          <year>2016</year>
<volume>89</volume>
<fpage>940</fpage>
<lpage>947</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2016.02.024</pub-id>
<pub-id pub-id-type="pmid">26938441</pub-id>
</element-citation>
</ref>
<ref id="B68-ijms-18-01404">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Najmabadi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Garshasbi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zemojtel</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Abedini</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hosseini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Behjati</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Haas</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jamali</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Deep sequencing reveals 50 novel genes for recessive cognitive disorders</article-title>
<source/>Nature
          <year>2011</year>
<volume>478</volume>
<fpage>57</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="doi">10.1038/nature10423</pub-id>
<pub-id pub-id-type="pmid">21937992</pub-id>
</element-citation>
</ref>
<ref id="B69-ijms-18-01404">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jensen</surname>
<given-names>L.R.</given-names>
</name>
<name>
<surname>Amende</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gurok</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Moser</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gimmel</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Tzschach</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Janecke</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Tariverdian</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Chelly</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fryns</surname>
<given-names>J.-P.</given-names>
</name>
</person-group>
<article-title>Mutations in the <italic>JARID1C</italic> gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation</article-title>
<source/>Am. J. Hum. Genet.
          <year>2005</year>
<volume>76</volume>
<fpage>227</fpage>
<lpage>236</lpage>
<pub-id pub-id-type="doi">10.1086/427563</pub-id>
<pub-id pub-id-type="pmid">15586325</pub-id>
</element-citation>
</ref>
<ref id="B70-ijms-18-01404">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tahiliani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mei</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Leonor</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rutenberg</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation</article-title>
<source/>Nature
          <year>2007</year>
<volume>447</volume>
<fpage>601</fpage>
<lpage>605</lpage>
<pub-id pub-id-type="doi">10.1038/nature05823</pub-id>
<pub-id pub-id-type="pmid">17468742</pub-id>
</element-citation>
</ref>
<ref id="B71-ijms-18-01404">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poeta</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fusco</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Drongitis</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Shoubridge</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Manganelli</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Filosa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Paciolla</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Courtney</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Collombat</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lioi</surname>
<given-names>M.B.</given-names>
</name>
</person-group>
<article-title>A regulatory path associated with X-linked intellectual disability and epilepsy links KDM5C to the polyalanine expansions in ARX</article-title>
<source/>Am. J. Hum. Genet.
          <year>2013</year>
<volume>92</volume>
<fpage>114</fpage>
<lpage>125</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2012.11.008</pub-id>
<pub-id pub-id-type="pmid">23246292</pub-id>
</element-citation>
</ref>
<ref id="B72-ijms-18-01404">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strømme</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mangelsdorf</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Scheffer</surname>
<given-names>I.E.</given-names>
</name>
<name>
<surname>Gécz</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Infantile spasms, dystonia, and other X-linked phenotypes caused by mutations in Aristaless related homeobox gene, <italic>ARX</italic></article-title>
<source/>Brain Dev.
          <year>2002</year>
<volume>24</volume>
<fpage>266</fpage>
<lpage>268</lpage>
<pub-id pub-id-type="doi">10.1016/S0387-7604(02)00079-7</pub-id>
<pub-id pub-id-type="pmid">12142061</pub-id>
</element-citation>
</ref>
<ref id="B73-ijms-18-01404">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kitamura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yanazawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sugiyama</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Miura</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Iizuka-Kogo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kusaka</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Omichi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kato-Fukui</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kamiirisa</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Mutation of <italic>ARX</italic> causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans</article-title>
<source/>Nat. Genet.
          <year>2002</year>
<volume>32</volume>
<fpage>359</fpage>
<lpage>369</lpage>
<pub-id pub-id-type="doi">10.1038/ng1009</pub-id>
<pub-id pub-id-type="pmid">12379852</pub-id>
</element-citation>
</ref>
<ref id="B74-ijms-18-01404">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Petras</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kitamura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Morohashi</surname>
<given-names>K.I.</given-names>
</name>
<name>
<surname>Abuelo</surname>
<given-names>D.N.</given-names>
</name>
<name>
<surname>Barr</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bonneau</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Brady</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Carpenter</surname>
<given-names>N.J.</given-names>
</name>
</person-group>
<article-title>Mutations of <italic>ARX</italic> are associated with striking pleiotropy and consistent genotype–phenotype correlation</article-title>
<source/>Hum. Mutat.
          <year>2004</year>
<volume>23</volume>
<fpage>147</fpage>
<lpage>159</lpage>
<pub-id pub-id-type="doi">10.1002/humu.10310</pub-id>
<pub-id pub-id-type="pmid">14722918</pub-id>
</element-citation>
</ref>
<ref id="B75-ijms-18-01404">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tunovic</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Barkovich</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sherr</surname>
<given-names>E.H.</given-names>
</name>
<name>
<surname>Slavotinek</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title><italic>De novo ANKRD11</italic> and <italic>KDM1A</italic> gene mutations in a male with features of KBG syndrome and Kabuki syndrome</article-title>
<source/>Am. J. Med. Genet.
          <year>2014</year>
<volume>164</volume>
<fpage>1744</fpage>
<lpage>1749</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.36450</pub-id>
<pub-id pub-id-type="pmid">24838796</pub-id>
</element-citation>
</ref>
<ref id="B76-ijms-18-01404">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Histone lysine demethylases: Emerging roles in development, physiology and disease</article-title>
<source/>Nat. Rev. Genet.
          <year>2007</year>
<volume>8</volume>
<fpage>829</fpage>
<lpage>833</lpage>
<pub-id pub-id-type="doi">10.1038/nrg2218</pub-id>
<pub-id pub-id-type="pmid">17909537</pub-id>
</element-citation>
</ref>
<ref id="B77-ijms-18-01404">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>De Cegli</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Alpatov</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Horton</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Gozani</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression</article-title>
<source/>Nature
          <year>2007</year>
<volume>448</volume>
<fpage>718</fpage>
<lpage>722</lpage>
<pub-id pub-id-type="doi">10.1038/nature06034</pub-id>
<pub-id pub-id-type="pmid">17687328</pub-id>
</element-citation>
</ref>
<ref id="B78-ijms-18-01404">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>H.-G.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.-T.</given-names>
</name>
<name>
<surname>Leach</surname>
<given-names>N.T.</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ullmann</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Silahtaroglu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kurth</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Nowka</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Seong</surname>
<given-names>I.S.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Translocations disrupting <italic>PHF21A</italic> in the Potocki-Shaffer-syndrome region are associated with intellectual disability and craniofacial anomalies</article-title>
<source/>Am. J. Hum. Genet.
          <year>2012</year>
<volume>91</volume>
<fpage>56</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2012.05.005</pub-id>
<pub-id pub-id-type="pmid">22770980</pub-id>
</element-citation>
</ref>
<ref id="B79-ijms-18-01404">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Labonne</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Vogt</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Reali</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>I.K.</given-names>
</name>
<name>
<surname>Layman</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.G.</given-names>
</name>
</person-group>
<article-title>A microdeletion encompassing <italic>PHF21A</italic> in an individual with global developmental delay and craniofacial anomalies</article-title>
<source/>Am. J. Med. Genet.
          <year>2015</year>
<volume>167</volume>
<fpage>3011</fpage>
<lpage>3018</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.37344</pub-id>
<pub-id pub-id-type="pmid">26333423</pub-id>
</element-citation>
</ref>
<ref id="B80-ijms-18-01404">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hakimi</surname>
<given-names>M.-A.</given-names>
</name>
<name>
<surname>Bochar</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Chenoweth</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Mandel</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Shiekhattar</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>A core–BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2002</year>
<volume>99</volume>
<fpage>7420</fpage>
<lpage>7425</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.112008599</pub-id>
<pub-id pub-id-type="pmid">12032298</pub-id>
</element-citation>
</ref>
<ref id="B81-ijms-18-01404">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleefstra</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Smidt</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Banning</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Oudakker</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Van Esch</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>De Brouwer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nillesen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Sistermans</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hamel</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>De Bruijn</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Disruption of the gene Euchromatin Histone Methyl Transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome</article-title>
<source/>J. Med. Genet.
          <year>2005</year>
<volume>42</volume>
<fpage>299</fpage>
<lpage>306</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.2004.028464</pub-id>
<pub-id pub-id-type="pmid">15805155</pub-id>
</element-citation>
</ref>
<ref id="B82-ijms-18-01404">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleefstra</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Brunner</surname>
<given-names>H.G.</given-names>
</name>
<name>
<surname>Amiel</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Oudakker</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Nillesen</surname>
<given-names>W.M.</given-names>
</name>
<name>
<surname>Magee</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Geneviève</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cormier-Daire</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Van Esch</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fryns</surname>
<given-names>J.-P.</given-names>
</name>
</person-group>
<article-title>Loss-of-function mutations in euchromatin histone methyl transferase 1 (<italic>EHMT1</italic>) cause the 9q34 subtelomeric deletion syndrome</article-title>
<source/>Am. J. Hum. Genet.
          <year>2006</year>
<volume>79</volume>
<fpage>370</fpage>
<lpage>377</lpage>
<pub-id pub-id-type="doi">10.1086/505693</pub-id>
<pub-id pub-id-type="pmid">16826528</pub-id>
</element-citation>
</ref>
<ref id="B83-ijms-18-01404">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harada</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Visser</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dawson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fukamachi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Iwakoshi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kishino</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Niikawa</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>A 1-Mb critical region in six patients with 9q34. 3 terminal deletion syndrome</article-title>
<source/>J. Hum. Genet.
          <year>2004</year>
<volume>49</volume>
<fpage>440</fpage>
<lpage>444</lpage>
<pub-id pub-id-type="doi">10.1007/s10038-004-0166-z</pub-id>
<pub-id pub-id-type="pmid">15258833</pub-id>
</element-citation>
</ref>
<ref id="B84-ijms-18-01404">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kramer</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Kochinke</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Oortveld</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Marks</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>de Jong</surname>
<given-names>E.K.</given-names>
</name>
<name>
<surname>Asztalos</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Westwood</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Stunnenberg</surname>
<given-names>H.G.</given-names>
</name>
<name>
<surname>Sokolowski</surname>
<given-names>M.B.</given-names>
</name>
</person-group>
<article-title>Epigenetic regulation of learning and memory by <italic>Drosophila</italic> EHMT/G9a</article-title>
<source/>PLoS Biol.
          <year>2011</year>
<volume>9</volume>
<elocation-id>e1000569</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pbio.1000569</pub-id>
<pub-id pub-id-type="pmid">21245904</pub-id>
</element-citation>
</ref>
<ref id="B85-ijms-18-01404">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balemans</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nadif Kasri</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kopanitsa</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Afinowi</surname>
<given-names>N.O.</given-names>
</name>
<name>
<surname>Ramakers</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Beynon</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Janssen</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>van Summeren</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Eeftens</surname>
<given-names>J.M.</given-names>
</name>
</person-group>
<article-title>Hippocampal dysfunction in the Euchromatin histone methyltransferase 1 heterozygous knockout mouse model for Kleefstra syndrome</article-title>
<source/>Hum. Mol. Genet.
          <year>2013</year>
<volume>22</volume>
<fpage>852</fpage>
<lpage>866</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/dds490</pub-id>
<pub-id pub-id-type="pmid">23175442</pub-id>
</element-citation>
</ref>
<ref id="B86-ijms-18-01404">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martens</surname>
<given-names>M.B.</given-names>
</name>
<name>
<surname>Frega</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Classen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Epping</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bijvank</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Benevento</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>van Bokhoven</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tiesinga</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Schubert</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kasri</surname>
<given-names>N.N.</given-names>
</name>
</person-group>
<article-title>Euchromatin histone methyltransferase 1 regulates cortical neuronal network development</article-title>
<source/>Sci. Rep.
          <year>2016</year>
<volume>6</volume>
<fpage>35756</fpage>
<pub-id pub-id-type="doi">10.1038/srep35756</pub-id>
<pub-id pub-id-type="pmid">27767173</pub-id>
</element-citation>
</ref>
<ref id="B87-ijms-18-01404">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benevento</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Iacono</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Selten</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ba</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Oudakker</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Frega</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mancini</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lewerissa</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kleefstra</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Histone methylation by the Kleefstra syndrome protein EHMT1 mediates homeostatic synaptic scaling</article-title>
<source/>Neuron
          <year>2016</year>
<volume>91</volume>
<fpage>341</fpage>
<lpage>355</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2016.06.003</pub-id>
<pub-id pub-id-type="pmid">27373831</pub-id>
</element-citation>
</ref>
<ref id="B88-ijms-18-01404">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleefstra</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Neveling</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Willemsen</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Koemans</surname>
<given-names>T.S.</given-names>
</name>
<name>
<surname>Vissers</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Wissink-Lindhout</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Fenckova</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>van den Akker</surname>
<given-names>W.M.</given-names>
</name>
<name>
<surname>Kasri</surname>
<given-names>N.N.</given-names>
</name>
</person-group>
<article-title>Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability</article-title>
<source/>Am. J. Hum. Genet.
          <year>2012</year>
<volume>91</volume>
<fpage>73</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2012.05.003</pub-id>
<pub-id pub-id-type="pmid">22726846</pub-id>
</element-citation>
</ref>
<ref id="B89-ijms-18-01404">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agha</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Iqbal</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Azam</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ayub</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Vissers</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Gilissen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>S.H.B.</given-names>
</name>
<name>
<surname>Riaz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Veltman</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Pfundt</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Exome sequencing identifies three novel candidate genes implicated in intellectual disability</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<elocation-id>e112687</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0112687</pub-id>
<pub-id pub-id-type="pmid">25405613</pub-id>
</element-citation>
</ref>
<ref id="B90-ijms-18-01404">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siderius</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Hamel</surname>
<given-names>B.C.</given-names>
</name>
<name>
<surname>van Bokhoven</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>de Jager</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>van den Helm</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kremer</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Heineman-de Boer</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Ropers</surname>
<given-names>H.H.</given-names>
</name>
<name>
<surname>Mariman</surname>
<given-names>E.C.</given-names>
</name>
</person-group>
<article-title>X-linked mental retardation associated with cleft lip/palate maps to Xp11.3-q21.3</article-title>
<source/>Am. J. Med. Genet.
          <year>1999</year>
<volume>85</volume>
<fpage>216</fpage>
<lpage>220</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19990730)85:3&lt;216::AID-AJMG6&gt;3.0.CO;2-X</pub-id>
<pub-id pub-id-type="pmid">10398231</pub-id>
</element-citation>
</ref>
<ref id="B91-ijms-18-01404">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laumonnier</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Holbert</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ronce</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Faravelli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lenzner</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lespinasse</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Van Esch</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lacombe</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Goizet</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Mutations in <italic>PHF8</italic> are associated with X linked mental retardation and cleft lip/cleft palate</article-title>
<source/>J. Med. Genet.
          <year>2005</year>
<volume>42</volume>
<fpage>780</fpage>
<lpage>786</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.2004.029439</pub-id>
<pub-id pub-id-type="pmid">16199551</pub-id>
</element-citation>
</ref>
<ref id="B92-ijms-18-01404">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abidi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Miano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>A novel mutation in the <italic>PHF8</italic> gene is associated with X-linked mental retardation with cleft lip/cleft palate</article-title>
<source/>Clin. Genet.
          <year>2007</year>
<volume>72</volume>
<fpage>19</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-0004.2007.00817.x</pub-id>
<pub-id pub-id-type="pmid">17594395</pub-id>
</element-citation>
</ref>
<ref id="B93-ijms-18-01404">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koivisto</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ala-Mello</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lemmelä</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Komu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rautio</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Järvelä</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Screening of mutations in the <italic>PHF8</italic> gene and identification of a novel mutation in a Finnish family with XLMR and cleft lip/cleft palate</article-title>
<source/>Clin. Genet.
          <year>2007</year>
<volume>72</volume>
<fpage>145</fpage>
<lpage>149</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-0004.2007.00836.x</pub-id>
<pub-id pub-id-type="pmid">17661819</pub-id>
</element-citation>
</ref>
<ref id="B94-ijms-18-01404">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yonezawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jenuwein</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Grummt</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>PHF8 activates transcription of rRNA genes through H3K4me3 binding and H3K9me1/2 demethylation</article-title>
<source/>Nat. Struct. Mol. Biol.
          <year>2010</year>
<volume>17</volume>
<fpage>445</fpage>
<lpage>450</lpage>
<pub-id pub-id-type="doi">10.1038/nsmb.1778</pub-id>
<pub-id pub-id-type="pmid">20208542</pub-id>
</element-citation>
</ref>
<ref id="B95-ijms-18-01404">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleine-Kohlbrecher</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Christensen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Vandamme</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Abarrategui</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Bak</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tommerup</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Gozani</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Rappsilber</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Salcini</surname>
<given-names>A.E.</given-names>
</name>
</person-group>
<article-title>A functional link between the histone demethylase PHF8 and the transcription factor ZNF711 in X-linked mental retardation</article-title>
<source/>Mol. Cell
          <year>2010</year>
<volume>38</volume>
<fpage>165</fpage>
<lpage>178</lpage>
<pub-id pub-id-type="doi">10.1016/j.molcel.2010.03.002</pub-id>
<pub-id pub-id-type="pmid">20346720</pub-id>
</element-citation>
</ref>
<ref id="B96-ijms-18-01404">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qi</surname>
<given-names>H.H.</given-names>
</name>
<name>
<surname>Sarkissian</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>G.-Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Bhattacharjee</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>D.B.</given-names>
</name>
<name>
<surname>Gonzales</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ongusaha</surname>
<given-names>P.P.</given-names>
</name>
<name>
<surname>Huarte</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Histone H4K20/H3K9 demethylase PHF8 regulates zebrafish brain and craniofacial development</article-title>
<source/>Nature
          <year>2010</year>
<volume>466</volume>
<fpage>503</fpage>
<lpage>507</lpage>
<pub-id pub-id-type="doi">10.1038/nature09261</pub-id>
<pub-id pub-id-type="pmid">20622853</pub-id>
</element-citation>
</ref>
<ref id="B97-ijms-18-01404">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riveiro</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Mariani</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Malmberg</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Amendola</surname>
<given-names>P.G.</given-names>
</name>
<name>
<surname>Peltonen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Salcini</surname>
<given-names>A.E.</given-names>
</name>
</person-group>
<article-title>JMJD-1.2/PHF8 controls axon guidance by regulating Hedgehog-like signaling</article-title>
<source/>Development
          <year>2017</year>
<volume>144</volume>
<fpage>856</fpage>
<lpage>865</lpage>
<pub-id pub-id-type="doi">10.1242/dev.142695</pub-id>
<pub-id pub-id-type="pmid">28126843</pub-id>
</element-citation>
</ref>
<ref id="B98-ijms-18-01404">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walsh</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>E.Y.</given-names>
</name>
<name>
<surname>Bagot</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Anselmo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Javidfar</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wojtkiewicz</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Cloutier</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Sadreyev</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title><italic>Phf8</italic> loss confers resistance to depression-like and anxiety-like behaviors in mice</article-title>
<source/>Nat. Commun.
          <year>2017</year>
<volume>8</volume>
<fpage>15142</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms15142</pub-id>
<pub-id pub-id-type="pmid">28485378</pub-id>
</element-citation>
</ref>
<ref id="B99-ijms-18-01404">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weaver</surname>
<given-names>D.D.</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>C.B.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>D.W.</given-names>
</name>
</person-group>
<article-title>A new overgrowth syndrome with accelerated skeletal maturation, unusual facies, and camptodactyly</article-title>
<source/>J. Pediatr.
          <year>1974</year>
<volume>84</volume>
<fpage>547</fpage>
<lpage>552</lpage>
<pub-id pub-id-type="doi">10.1016/S0022-3476(74)80675-X</pub-id>
<pub-id pub-id-type="pmid">4366187</pub-id>
</element-citation>
</ref>
<ref id="B100-ijms-18-01404">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>M.M.</given-names>
</name>
</person-group>
<article-title>Mental deficiency, alterations in performance, and CNS abnormalities in overgrowth syndromes</article-title>
<source/>Am. J. Med. Genet.
          <year>2003</year>
<volume>117C</volume>
<fpage>49</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.c.10013</pub-id>
<pub-id pub-id-type="pmid">12561058</pub-id>
</element-citation>
</ref>
<ref id="B101-ijms-18-01404">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tatton-Brown</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hanks</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Douglas</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Armstrong</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Banka</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Clericuzio</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Cormier-Daire</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Cushing</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Weaver syndrome and <italic>EZH2</italic> mutations: Clarifying the clinical phenotype</article-title>
<source/>Am. J. Med. Genet.
          <year>2013</year>
<volume>161</volume>
<fpage>2972</fpage>
<lpage>2980</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.36229</pub-id>
<pub-id pub-id-type="pmid">24214728</pub-id>
</element-citation>
</ref>
<ref id="B102-ijms-18-01404">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tatton-Brown</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hanks</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ruark</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Zachariou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Duarte</surname>
<given-names>S.D.V.</given-names>
</name>
<name>
<surname>Ramsay</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Snape</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Perdeaux</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Seal</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Germline mutations in the oncogene <italic>EZH2</italic> cause Weaver syndrome and increased human height</article-title>
<source/>Oncotarget
          <year>2011</year>
<volume>2</volume>
<fpage>1127</fpage>
<lpage>1133</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.385</pub-id>
<pub-id pub-id-type="pmid">22190405</pub-id>
</element-citation>
</ref>
<ref id="B103-ijms-18-01404">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gibson</surname>
<given-names>W.T.</given-names>
</name>
<name>
<surname>Hood</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Bulman</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Fejes</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mungall</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Eydoux</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Babul-Hirji</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>An</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Mutations in <italic>EZH2</italic> cause Weaver syndrome</article-title>
<source/>Am. J. Hum. Genet.
          <year>2012</year>
<volume>90</volume>
<fpage>110</fpage>
<lpage>118</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2011.11.018</pub-id>
<pub-id pub-id-type="pmid">22177091</pub-id>
</element-citation>
</ref>
<ref id="B104-ijms-18-01404">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Erdjument-Bromage</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tempst</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Role of histone H3 lysine 27 methylation in Polycomb-group silencing</article-title>
<source/>Science
          <year>2002</year>
<volume>298</volume>
<fpage>1039</fpage>
<lpage>1043</lpage>
<pub-id pub-id-type="doi">10.1126/science.1076997</pub-id>
<pub-id pub-id-type="pmid">12351676</pub-id>
</element-citation>
</ref>
<ref id="B105-ijms-18-01404">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Tuysuz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bhalla</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>W.T.</given-names>
</name>
</person-group>
<article-title>A novel mutation in <italic>EED</italic> associated with overgrowth</article-title>
<source/>J. Hum. Genet.
          <year>2015</year>
<volume>60</volume>
<fpage>339</fpage>
<lpage>342</lpage>
<pub-id pub-id-type="doi">10.1038/jhg.2015.26</pub-id>
<pub-id pub-id-type="pmid">25787343</pub-id>
</element-citation>
</ref>
<ref id="B106-ijms-18-01404">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pereira</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Sansom</surname>
<given-names>S.N.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dobenecker</surname>
<given-names>M.-W.</given-names>
</name>
<name>
<surname>Tarakhovsky</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Livesey</surname>
<given-names>F.J.</given-names>
</name>
</person-group>
<article-title>Ezh2, the histone methyltransferase of PRC2, regulates the balance between self-renewal and differentiation in the cerebral cortex</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2010</year>
<volume>107</volume>
<fpage>15957</fpage>
<lpage>15962</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1002530107</pub-id>
<pub-id pub-id-type="pmid">20798045</pub-id>
</element-citation>
</ref>
<ref id="B107-ijms-18-01404">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Juan</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.A.</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Zare</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sartorelli</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Polycomb Ezh2 controls the fate of GABAergic neurons in the embryonic cerebellum</article-title>
<source/>Development
          <year>2016</year>
<volume>143</volume>
<fpage>1971</fpage>
<lpage>1980</lpage>
<pub-id pub-id-type="doi">10.1242/dev.132902</pub-id>
<pub-id pub-id-type="pmid">27068104</pub-id>
</element-citation>
</ref>
<ref id="B108-ijms-18-01404">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akizu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>García</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Estarás</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fueyo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Badosa</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>de la Cruz</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Martínez-Balbás</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>EZH2 regulates neuroepithelium structure and neuroblast proliferation by repressing p21</article-title>
<source/>Open Biol.
          <year>2016</year>
<volume>6</volume>
<fpage>150227</fpage>
<pub-id pub-id-type="doi">10.1098/rsob.150227</pub-id>
<pub-id pub-id-type="pmid">27248655</pub-id>
</element-citation>
</ref>
<ref id="B109-ijms-18-01404">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jiao</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Ezh2 regulates adult hippocampal neurogenesis and memory</article-title>
<source/>J. Neurosci.
          <year>2014</year>
<volume>34</volume>
<fpage>5184</fpage>
<lpage>5199</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4129-13.2014</pub-id>
<pub-id pub-id-type="pmid">24719098</pub-id>
</element-citation>
</ref>
<ref id="B110-ijms-18-01404">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>La Torre</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wilken</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Reh</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Vetter</surname>
<given-names>M.L.</given-names>
</name>
</person-group>
<article-title>Ezh2 maintains retinal progenitor proliferation, transcriptional integrity, and the timing of late differentiation</article-title>
<source/>Dev. Biol.
          <year>2015</year>
<volume>403</volume>
<fpage>128</fpage>
<lpage>138</lpage>
<pub-id pub-id-type="doi">10.1016/j.ydbio.2015.05.010</pub-id>
<pub-id pub-id-type="pmid">25989023</pub-id>
</element-citation>
</ref>
<ref id="B111-ijms-18-01404">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirabayashi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Suzki</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Tsuboi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Endo</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Toyoda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shinga</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Koseki</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Vidal</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gotoh</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Polycomb limits the neurogenic competence of neural precursor cells to promote astrogenic fate transition</article-title>
<source/>Neuron
          <year>2009</year>
<volume>63</volume>
<fpage>600</fpage>
<lpage>613</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2009.08.021</pub-id>
<pub-id pub-id-type="pmid">19755104</pub-id>
</element-citation>
</ref>
<ref id="B112-ijms-18-01404">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>Y.-L.</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>R.-H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.-T.</given-names>
</name>
<name>
<surname>Shyu</surname>
<given-names>W.-C.</given-names>
</name>
<name>
<surname>Hsieh</surname>
<given-names>S.-C.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>C.-S.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>H.-J.</given-names>
</name>
<name>
<surname>Yeh</surname>
<given-names>S.-P.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>D.-M.</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>S.-C.</given-names>
</name>
</person-group>
<article-title>EZH2 regulates neuronal differentiation of mesenchymal stem cells through PIP5K1C-dependent calcium signaling</article-title>
<source/>J. Biol. Chem.
          <year>2011</year>
<volume>286</volume>
<fpage>9657</fpage>
<lpage>9667</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M110.185124</pub-id>
<pub-id pub-id-type="pmid">21216957</pub-id>
</element-citation>
</ref>
<ref id="B113-ijms-18-01404">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hwang</surname>
<given-names>W.W.</given-names>
</name>
<name>
<surname>Salinas</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Siu</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Kelley</surname>
<given-names>K.W.</given-names>
</name>
<name>
<surname>Delgado</surname>
<given-names>R.N.</given-names>
</name>
<name>
<surname>Paredes</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Alvarez-Buylla</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Oldham</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>Distinct and separable roles for EZH2 in neurogenic astroglia</article-title>
<source/>Elife
          <year>2014</year>
<volume>3</volume>
<fpage>e02439</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.02439</pub-id>
<pub-id pub-id-type="pmid">24867641</pub-id>
</element-citation>
</ref>
<ref id="B114-ijms-18-01404">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Meglio</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kratochwil</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Vilain</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Loche</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vitobello</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yonehara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hrycaj</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Roska</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Eichmann</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Ezh2 orchestrates topographic migration and connectivity of mouse precerebellar neurons</article-title>
<source/>Science
          <year>2013</year>
<volume>339</volume>
<fpage>204</fpage>
<lpage>207</lpage>
<pub-id pub-id-type="doi">10.1126/science.1229326</pub-id>
<pub-id pub-id-type="pmid">23307742</pub-id>
</element-citation>
</ref>
<ref id="B115-ijms-18-01404">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Rank</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>Y.T.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Moritz</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Cerruti</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Curtis</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Allis</surname>
<given-names>C.D.</given-names>
</name>
</person-group>
<article-title>PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing</article-title>
<source/>Nat. Struct. Mol. Biol.
          <year>2009</year>
<volume>16</volume>
<fpage>304</fpage>
<lpage>311</lpage>
<pub-id pub-id-type="doi">10.1038/nsmb.1568</pub-id>
<pub-id pub-id-type="pmid">19234465</pub-id>
</element-citation>
</ref>
<ref id="B116-ijms-18-01404">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tien</surname>
<given-names>C.-L.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gerigk</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nozell</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Snail2/Slug cooperates with Polycomb repressive complex 2 (PRC2) to regulate neural crest development</article-title>
<source/>Development
          <year>2015</year>
<volume>142</volume>
<fpage>722</fpage>
<lpage>731</lpage>
<pub-id pub-id-type="doi">10.1242/dev.111997</pub-id>
<pub-id pub-id-type="pmid">25617436</pub-id>
</element-citation>
</ref>
<ref id="B117-ijms-18-01404">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kurotaki</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Imaizumi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Harada</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Masuno</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kondoh</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nagai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ohashi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Naritomi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tsukahara</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Makita</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Haploinsufficiency of <italic>NSD1</italic> causes Sotos syndrome</article-title>
<source/>Nat. Genet.
          <year>2002</year>
<volume>30</volume>
<fpage>365</fpage>
<lpage>366</lpage>
<pub-id pub-id-type="doi">10.1038/ng863</pub-id>
<pub-id pub-id-type="pmid">11896389</pub-id>
</element-citation>
</ref>
<ref id="B118-ijms-18-01404">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sotos</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Dodge</surname>
<given-names>P.R.</given-names>
</name>
<name>
<surname>Muirhead</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Talbot</surname>
<given-names>N.B.</given-names>
</name>
</person-group>
<article-title>Cerebral gigantism in childhood: A syndrome of excessively rapid growth with acromegalic features and a nonprogressive neurologic disorder</article-title>
<source/>N. Engl. J. Med.
          <year>1964</year>
<volume>271</volume>
<fpage>109</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM196407162710301</pub-id>
<pub-id pub-id-type="pmid">14148233</pub-id>
</element-citation>
</ref>
<ref id="B119-ijms-18-01404">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Žilina</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Reimand</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tammur</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tillmann</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Kurg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Õunap</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Patient with dup (5) (q35.2-q35.3) reciprocal to the common Sotos syndrome deletion and review of the literature</article-title>
<source/>Eur. J. Med. Genet.
          <year>2013</year>
<volume>56</volume>
<fpage>202</fpage>
<lpage>206</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejmg.2013.01.008</pub-id>
<pub-id pub-id-type="pmid">23369838</pub-id>
</element-citation>
</ref>
<ref id="B120-ijms-18-01404">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berdasco</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ropero</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Setien</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Fraga</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Lapunzina</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Losson</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Alaminos</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>N.-K.</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Esteller</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2009</year>
<volume>106</volume>
<fpage>21830</fpage>
<lpage>21835</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0906831106</pub-id>
<pub-id pub-id-type="pmid">20018718</pub-id>
</element-citation>
</ref>
<ref id="B121-ijms-18-01404">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Visser</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Landman</surname>
<given-names>E.B.</given-names>
</name>
<name>
<surname>Goeman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wit</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Karperien</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Sotos syndrome is associated with deregulation of the MAPK/ERK-signaling pathway</article-title>
<source/>PLoS ONE
          <year>2012</year>
<volume>7</volume>
<elocation-id>e49229</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0049229</pub-id>
<pub-id pub-id-type="pmid">23155469</pub-id>
</element-citation>
</ref>
<ref id="B122-ijms-18-01404">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malan</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Rajan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Louis Dit Picard</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Layet</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Till</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>van Haeringen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mortier</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Nampoothiri</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Distinct effects of allelic <italic>NFIX</italic> mutations on nonsense-mediated mRNA decay engender either a Sotos-like or a Marshall-Smith syndrome</article-title>
<source/>Am. J. Hum. Genet.
          <year>2010</year>
<volume>87</volume>
<fpage>189</fpage>
<lpage>198</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2010.07.001</pub-id>
<pub-id pub-id-type="pmid">20673863</pub-id>
</element-citation>
</ref>
<ref id="B123-ijms-18-01404">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Almuriekhi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shintani</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fahiminiya</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fujikawa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kuboyama</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Takeuchi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nawaz</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Nadaf</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kamel</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kitam</surname>
<given-names>A.K.</given-names>
</name>
</person-group>
<article-title>Loss-of-function mutation in <italic>APC2</italic> causes Sotos syndrome features</article-title>
<source/>Cell Rep.
          <year>2015</year>
<volume>10</volume>
<fpage>1585</fpage>
<lpage>1598</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2015.02.011</pub-id>
<pub-id pub-id-type="pmid">25753423</pub-id>
</element-citation>
</ref>
<ref id="B124-ijms-18-01404">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Engström</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lindham</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schofield</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Wiedemann-Beckwith syndrome</article-title>
<source/>Eur. J. Pediatr.
          <year>1988</year>
<volume>147</volume>
<fpage>450</fpage>
<lpage>457</lpage>
<pub-id pub-id-type="doi">10.1007/BF00441965</pub-id>
<pub-id pub-id-type="pmid">3044795</pub-id>
</element-citation>
</ref>
<ref id="B125-ijms-18-01404">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martínez-y-Martínez</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Martínez-Carboney</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ocampo-Campos</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rivera</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cuevas</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Martín</surname>
<given-names>M.M.</given-names>
</name>
</person-group>
<article-title>Wiedemann-Beckwith syndrome: Clinical, cytogenetical and radiological observations in 39 new cases</article-title>
<source/>Genet. Couns.
          <year>1992</year>
<volume>3</volume>
<fpage>67</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="pmid">1642813</pub-id>
</element-citation>
</ref>
<ref id="B126-ijms-18-01404">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waziri</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Patil</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Bartley</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Abnormality of chromosome 11 in patients with features of Beckwith-Wiedemann syndrome</article-title>
<source/>J. Pediatr.
          <year>1983</year>
<volume>102</volume>
<fpage>873</fpage>
<lpage>876</lpage>
<pub-id pub-id-type="doi">10.1016/S0022-3476(83)80014-6</pub-id>
<pub-id pub-id-type="pmid">6854451</pub-id>
</element-citation>
</ref>
<ref id="B127-ijms-18-01404">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baujat</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Rio</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rossignol</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sanlaville</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lyonnet</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Le Merrer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Munnich</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gicquel</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cormier-Daire</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Colleaux</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Paradoxical <italic>NSD1</italic> mutations in Beckwith-Wiedemann syndrome and 11p15 anomalies in Sotos syndrome</article-title>
<source/>Am. J. Hum. Genet.
          <year>2004</year>
<volume>74</volume>
<fpage>715</fpage>
<lpage>720</lpage>
<pub-id pub-id-type="doi">10.1086/383093</pub-id>
<pub-id pub-id-type="pmid">14997421</pub-id>
</element-citation>
</ref>
<ref id="B128-ijms-18-01404">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Battaglia</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Carey</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Cederholm</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Viskochil</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Brothman</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Galasso</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Natural history of Wolf-Hirschhorn syndrome: Experience with 15 cases</article-title>
<source/>Pediatrics
          <year>1999</year>
<volume>103</volume>
<fpage>830</fpage>
<lpage>836</lpage>
<pub-id pub-id-type="doi">10.1542/peds.103.4.830</pub-id>
<pub-id pub-id-type="pmid">10103318</pub-id>
</element-citation>
</ref>
<ref id="B129-ijms-18-01404">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Näf</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Bergstrom</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Goodwin</surname>
<given-names>N.C.</given-names>
</name>
<name>
<surname>Verkerk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>van Ommen</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Ackerman</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Frankel</surname>
<given-names>W.N.</given-names>
</name>
<name>
<surname>Schimenti</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>Mouse models for the Wolf–Hirschhorn deletion syndrome</article-title>
<source/>Hum. Mol. Genet.
          <year>2001</year>
<volume>10</volume>
<fpage>91</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/10.2.91</pub-id>
<pub-id pub-id-type="pmid">11152656</pub-id>
</element-citation>
</ref>
<ref id="B130-ijms-18-01404">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>Y.F.</given-names>
</name>
<name>
<surname>Nimura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lo</surname>
<given-names>W.N.</given-names>
</name>
<name>
<surname>Saga</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kaneda</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Histone H3 lysine 36 methyltransferase Whsc1 promotes the association of RUNX2 and p300 in the activation of bone-related genes</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<elocation-id>e106661</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0106661</pub-id>
<pub-id pub-id-type="pmid">25188294</pub-id>
</element-citation>
</ref>
<ref id="B131-ijms-18-01404">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bicknell</surname>
<given-names>L.S.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Klingseisen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stiff</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Leitch</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kerzendorfer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>C.-A.</given-names>
</name>
<name>
<surname>Yeyati</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Al Sanna</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bober</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Mutations in <italic>ORC1</italic>, encoding the largest subunit of the origin recognition complex, cause microcephalic primordial dwarfism resembling Meier-Gorlin syndrome</article-title>
<source/>Nat. Genet.
          <year>2011</year>
<volume>43</volume>
<fpage>350</fpage>
<lpage>355</lpage>
<pub-id pub-id-type="doi">10.1038/ng.776</pub-id>
<pub-id pub-id-type="pmid">21358633</pub-id>
</element-citation>
</ref>
<ref id="B132-ijms-18-01404">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shalev</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>J.G.</given-names>
</name>
</person-group>
<article-title>Another adult with Meier-Gorlin syndrome-insights into the natural history</article-title>
<source/>Clin. Dysmorphol.
          <year>2003</year>
<volume>12</volume>
<fpage>167</fpage>
<lpage>169</lpage>
<pub-id pub-id-type="doi">10.1097/01.mcd.0000065052.36236.32</pub-id>
<pub-id pub-id-type="pmid">14564153</pub-id>
</element-citation>
</ref>
<ref id="B133-ijms-18-01404">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bicknell</surname>
<given-names>L.S.</given-names>
</name>
<name>
<surname>Bongers</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Leitch</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schoots</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Harley</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Aftimos</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Al-Aama</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Bober</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>Mutations in the pre-replication complex cause Meier-Gorlin syndrome</article-title>
<source/>Nat. Genet.
          <year>2011</year>
<volume>43</volume>
<fpage>356</fpage>
<lpage>359</lpage>
<pub-id pub-id-type="doi">10.1038/ng.775</pub-id>
<pub-id pub-id-type="pmid">21358632</pub-id>
</element-citation>
</ref>
<ref id="B134-ijms-18-01404">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peter</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Akbarian</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Balancing histone methylation activities in psychiatric disorders</article-title>
<source/>Trends Mol. Med.
          <year>2011</year>
<volume>17</volume>
<fpage>372</fpage>
<lpage>379</lpage>
<pub-id pub-id-type="doi">10.1016/j.molmed.2011.02.003</pub-id>
<pub-id pub-id-type="pmid">21429800</pub-id>
</element-citation>
</ref>
<ref id="B135-ijms-18-01404">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Copeland</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Solomon</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Richon</surname>
<given-names>V.M.</given-names>
</name>
</person-group>
<article-title>Protein methyltransferases as a target class for drug discovery</article-title>
<source/>Nat. Rev. Drug Discov.
          <year>2009</year>
<volume>8</volume>
<fpage>724</fpage>
<lpage>732</lpage>
<pub-id pub-id-type="doi">10.1038/nrd2974</pub-id>
<pub-id pub-id-type="pmid">19721445</pub-id>
</element-citation>
</ref>
<ref id="B136-ijms-18-01404">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Epigenetic targets and drug discovery: Part 1: Histone methylation</article-title>
<source/>Pharmacol. Ther.
          <year>2014</year>
<volume>143</volume>
<fpage>275</fpage>
<lpage>294</lpage>
<pub-id pub-id-type="doi">10.1016/j.pharmthera.2014.03.007</pub-id>
<pub-id pub-id-type="pmid">24704322</pub-id>
</element-citation>
</ref>
<ref id="B137-ijms-18-01404">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knutson</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Wigle</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Warholic</surname>
<given-names>N.M.</given-names>
</name>
<name>
<surname>Sneeringer</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Allain</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Klaus</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Sacks</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Raimondi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Majer</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells</article-title>
<source/>Nat. Chem. Biol.
          <year>2012</year>
<volume>8</volume>
<fpage>890</fpage>
<lpage>896</lpage>
<pub-id pub-id-type="doi">10.1038/nchembio.1084</pub-id>
<pub-id pub-id-type="pmid">23023262</pub-id>
</element-citation>
</ref>
<ref id="B138-ijms-18-01404">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCabe</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Ott</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Ganji</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Korenchuk</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Van Aller</surname>
<given-names>G.S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Graves</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Diaz</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>LaFrance</surname>
<given-names>L.V.</given-names>
</name>
</person-group>
<article-title>EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations</article-title>
<source/>Nature
          <year>2012</year>
<volume>492</volume>
<fpage>108</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="doi">10.1038/nature11606</pub-id>
<pub-id pub-id-type="pmid">23051747</pub-id>
</element-citation>
</ref>
<ref id="B139-ijms-18-01404">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qi</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Teng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chuai</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2012</year>
<volume>109</volume>
<fpage>21360</fpage>
<lpage>21365</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1210371110</pub-id>
<pub-id pub-id-type="pmid">23236167</pub-id>
</element-citation>
</ref>
<ref id="B140-ijms-18-01404">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Sætrom</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Snøve</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>MicroRNA-directed transcriptional gene silencing in mammalian cells</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2008</year>
<volume>105</volume>
<fpage>16230</fpage>
<lpage>16235</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0808830105</pub-id>
<pub-id pub-id-type="pmid">18852463</pub-id>
</element-citation>
</ref>
<ref id="B141-ijms-18-01404">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varambally</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Mani</surname>
<given-names>R.-S.</given-names>
</name>
<name>
<surname>Shankar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ateeq</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Laxman</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ramnarayanan</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer</article-title>
<source/>Science
          <year>2008</year>
<volume>322</volume>
<fpage>1695</fpage>
<lpage>1699</lpage>
<pub-id pub-id-type="doi">10.1126/science.1165395</pub-id>
<pub-id pub-id-type="pmid">19008416</pub-id>
</element-citation>
</ref>
<ref id="B142-ijms-18-01404">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hawkins</surname>
<given-names>P.G.</given-names>
</name>
<name>
<surname>Santoso</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Anest</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>K.V.</given-names>
</name>
</person-group>
<article-title>Promoter targeted small RNAs induce long-term transcriptional gene silencing in human cells</article-title>
<source/>Nucleic Acids Res.
          <year>2009</year>
<volume>37</volume>
<fpage>2984</fpage>
<lpage>2995</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkp127</pub-id>
<pub-id pub-id-type="pmid">19304753</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="ijms-18-01404-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Histone methylation and neurodevelopmental disorders: (<bold>a</bold>) histone methylation sites in the tails of histone H3 and H4; and (<bold>b</bold>) histone methyltransferases, demethylases, and methylated histone binding proteins linked with neurodevelopmental disorders. Five methylation sites were associated with several neurodevelopmental disorders. BWS, Beckwith-Wiedemann syndrome; KABUK1/2, Kabuki syndrome 1/2; KBGS, KBG syndrome; KS, Kleefstra syndrome; MGORS1, Meier-Gorlin syndrome 1; MRXSCJ, Mental retardation, X-linked, syndromic, Claes-Jensen type; MRXSSD, Siderius X-linked mental retardation syndrome; PSS, Potocki-Shaffer syndrome; SCZD, Schizophrenia; SOTOS1, Sotos syndrome 1; WDSTS, Wiedemann-Steiner syndrome; WHS, Wolf-Hirshhorn syndrome; WVS, Weaver syndrome.</p>
</caption>
<graphic xlink:href="ijms-18-01404-g001"></graphic>
</fig>
<table-wrap id="ijms-18-01404-t001" orientation="portrait" position="float">
<object-id pub-id-type="pii">ijms-18-01404-t001_Table 1</object-id>
<label>Table 1</label>
<caption>
<p>The names of the histone methylation-related factors mentioned in this paper and their synonyms.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Symbol</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Previous Symbol</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Synonym(s)</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Residue</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Function</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">ASH1L</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ASH1L</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ASH1, ASH1L1, huASH1, KMT2H</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K36</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">DOT1L</td>
<td align="center" colspan="1" rowspan="1" valign="middle">DOT1L </td>
<td align="center" colspan="1" rowspan="1" valign="middle">DOT1, KIAA1814, KMT4</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K79</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">EHMT1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">EHMT1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">bA188C12.1, Eu-HMTase1, FLJ12879, KIAA1876, KMT1D</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K9</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">EHMT2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">BAT8, C6orf30</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Em:AF134726.3, G9A, KMT1C, NG36/G9a</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K9</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">EZH1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">EZH1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">KIAA0388, KMT6B </td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K27</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">EZH2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">EZH2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENX-1, EZH1, KMT6, KMT6A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K27</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">KDM1A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">AOF2, KDM1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">BHC110, KIAA0601, LSD1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K4, H3K9, H4K20</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Demethylase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">KDM2A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">FBXL11, KDM2A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">CXXC8, DKFZP434M1735, FBL11, FBL7, FLJ00115, JHDM1A, KIAA1004, LILINA</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K36</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Demethylase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">KDM2B</td>
<td align="center" colspan="1" rowspan="1" valign="middle">FBXL10, KDM2B</td>
<td align="center" colspan="1" rowspan="1" valign="middle">CXXC2, Fbl10, JHDM1B, PCCX2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K36</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Demethylase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">KDM3A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">JMJD1, JMJD1A, KDM3A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">JHMD2A, KIAA0742, TSGA</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K9</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Demethylase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">KDM3B</td>
<td align="center" colspan="1" rowspan="1" valign="middle">C5orf7, JMJD1B, KDM3B</td>
<td align="center" colspan="1" rowspan="1" valign="middle">KIAA1082, NET22 </td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K9</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Demethylase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">KDM4A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">JMJD2, JMJD2A, KDM4A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">JHDM3A, KIAA0677, TDRD14A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K9, H3K36</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Demethylase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">KDM4B</td>
<td align="center" colspan="1" rowspan="1" valign="middle">JMJD2B, KDM4B</td>
<td align="center" colspan="1" rowspan="1" valign="middle">KIAA0876, TDRD14B </td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K9, H3K36</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Demethylase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">KDM4C</td>
<td align="center" colspan="1" rowspan="1" valign="middle">JMJD2C, KDM4C</td>
<td align="center" colspan="1" rowspan="1" valign="middle">GASC1, KIAA0780, TDRD14C</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K9, H3K36</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Demethylase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">KDM5A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">JARID1A, KDM5A, RBBP2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">-</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K4</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Demethylase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">KDM5C</td>
<td align="center" colspan="1" rowspan="1" valign="middle">JARID1C, KDM5C, MRX13, SMCX</td>
<td align="center" colspan="1" rowspan="1" valign="middle">DXS1272E, XE169 </td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K4</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Demethylase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">KDM6A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">KDM6A, UTX</td>
<td align="center" colspan="1" rowspan="1" valign="middle">-</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K27</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Demethylase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">KDM6B</td>
<td align="center" colspan="1" rowspan="1" valign="middle">JMJD3, KDM6B</td>
<td align="center" colspan="1" rowspan="1" valign="middle">KIAA0346</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K27</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Demethylase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">KMT2A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">KMT2A, MLL</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ALL-1, CXXC7, HRX, HTRX1, MLL1A, TRX1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K4</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">KMT2B</td>
<td align="center" colspan="1" rowspan="1" valign="middle">KMT2B</td>
<td align="center" colspan="1" rowspan="1" valign="middle">CXXC10, HRX2, KIAA0304, MLL1B, MLL2, MLL4, TRX2, WBP7</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K4</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">KMT2C</td>
<td align="center" colspan="1" rowspan="1" valign="middle">KMT2C, MLL3</td>
<td align="center" colspan="1" rowspan="1" valign="middle">HALR, KIAA1506</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K4</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">KMT2D</td>
<td align="center" colspan="1" rowspan="1" valign="middle">KMT2D, MLL2, TNRC21</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ALR, CAGL114, MLL4</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K4</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">KMT5A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">KMT5A, SETD8</td>
<td align="center" colspan="1" rowspan="1" valign="middle">PR-Set7, SET07, SET8</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H4K20</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">KMT5B</td>
<td align="center" colspan="1" rowspan="1" valign="middle">KMT5B, SUV420H1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">CGI-85</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H4K20</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">KMT5C</td>
<td align="center" colspan="1" rowspan="1" valign="middle">KMT5C, SUV420H2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">MGC2705</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H4K20</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">NSD1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">STO</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ARA267, FLJ22263, KMT3B</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K36</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">NSD2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">WHSC1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">KMT3G, MMSET</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K36</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">NSD3</td>
<td align="center" colspan="1" rowspan="1" valign="middle">WHSC1L1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">FLJ20353, KMT3F, WHISTLE </td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K36</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">ORC1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ORC1L</td>
<td align="center" colspan="1" rowspan="1" valign="middle">HSORC1, PARC1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H4K20</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Recognition</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">PHF2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">-</td>
<td align="center" colspan="1" rowspan="1" valign="middle">CENP-35, JHDM1E, KDM7C, KIAA0662</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K9, H4K20</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Demethylase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">PHF8</td>
<td align="center" colspan="1" rowspan="1" valign="middle">-</td>
<td align="center" colspan="1" rowspan="1" valign="middle">JHDM1F, KDM7B, KIAA1111, ZNF422</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K9, H4K20/H3K4</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Demethylase/Recognition</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">PHF21A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">-</td>
<td align="center" colspan="1" rowspan="1" valign="middle">BHC80, BM-006, KIAA1696</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K4</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Recognition</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">RIOX1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">C14orf169 </td>
<td align="center" colspan="1" rowspan="1" valign="middle">FLJ21802, JMJD9, MAPJD, NO66</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K4, H3K36</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Demethylase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">SETD1A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">-</td>
<td align="center" colspan="1" rowspan="1" valign="middle">KIAA0339, KMT2F, Set1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K4</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">SETD1B</td>
<td align="center" colspan="1" rowspan="1" valign="middle">-</td>
<td align="center" colspan="1" rowspan="1" valign="middle">KIAA1076, KMT2G, Set1B </td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K4</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">SETD2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">-</td>
<td align="center" colspan="1" rowspan="1" valign="middle">FLJ23184, HIF-1, HYPB, KIAA1732, KMT3A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K36</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">SETD3</td>
<td align="center" colspan="1" rowspan="1" valign="middle">C14orf154</td>
<td align="center" colspan="1" rowspan="1" valign="middle">FLJ23027</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K4, H3K36</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">SETDB1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">SETDB1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ESET, KG1T, KIAA0067, KMT1E, TDRD21 </td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K9</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">SETMAR</td>
<td align="center" colspan="1" rowspan="1" valign="middle">-</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Mentase</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K4, H3K36</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">SMYD2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">-</td>
<td align="center" colspan="1" rowspan="1" valign="middle">HSKM-B, KMT3C, ZMYND14</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K4, H3K36</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">SUV39H1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">SUV39H </td>
<td align="center" colspan="1" rowspan="1" valign="middle">KMT1A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K9</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">SUV39H2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">SUV39H2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">KMT1B FLJ23414 </td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K9</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">UTY</td>
<td align="center" colspan="1" rowspan="1" valign="middle">UTY</td>
<td align="center" colspan="1" rowspan="1" valign="middle">KDM6AL, KDM6C </td>
<td align="center" colspan="1" rowspan="1" valign="middle">H3K27</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Demethylase</td>
</tr>
<tr>
<td align="center" colspan="5" rowspan="1" style="border-bottom:solid thin" valign="middle">The names of the proteins are followed by HUGO Gene Nomenclature Committee (<uri xlink:href="http://www.genenames.org/">http://www.genenames.org/</uri>)</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="ijms-18-01404-t002" orientation="portrait" position="float">
<object-id pub-id-type="pii">ijms-18-01404-t002_Table 2</object-id>
<label>Table 2</label>
<caption>
<p>Neurodevelopmental disorders caused by mutations in histone methylation-related genes.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Disorder</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">OMIM</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Symptom</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Gene</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Residue</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Function</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Beckwith-Wiedemann syndrome (BWS)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">130650</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Pediatric overgrowth disorder involving a predisposition to tumor development</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>NSD1</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">H3K36</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Kabuki syndrome 1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">147920</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Congenital mental retardation, postnatal dwarfism, peculiar faces, broad and depressed nasal tip, large prominent earlobes, cleft or high-arched palate, scoliosis, short fifth finger, and persistence of finger pads</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">
<italic>KMT2D KDM6A</italic>
</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">H3K4 H3K27</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Methyltransferase Demethylase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Kabuki syndrome 2 (KABUK1/2)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">300867</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">KBG syndrome (KBGS)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">148050</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Macrodontia of the upper central incisors, distinctive craniofacial findings, short stature, skeletal anomalies, neurologic involvement that includes global developmental delay, seizures, and intellectual disability</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>KDM1A</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">H3K4 H3K9 H4K20</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Demethylase Demethylase Demethylase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Kleefstra syndrome (KS)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">610253</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Severe mental retardation, hypotonia, epileptic seizures, flat face with hypertelorism, synophrys, anteverted nares, everted lower lip, carp mouth with macroglossia, and heart defects</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>KMT2B, KMT2C EHMT1</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">H3K4 H3K4 H3K9</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Methyltransferase Methyltransferase Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Meier-Gorlin syndrome 1 (MGORS1)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">224690</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Severe intrauterine and postnatal growth retardation, microcephaly, bilateral microtia, and aplasia or hypoplasia of the patellae</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ORC1</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">H4K20</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Recognition</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mental retardation, X-linked, syndromic, Claes-Jensen type (MRXSCJ)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">300534</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Severe mental retardation, slowly progressive spastic paraplegia, facial hypotonia, and maxillary hypoplasia</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>KDM5C</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">H3K4</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Demethylase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Potocki-Shaffer syndrome (PSS)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">601224</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Craniofacial abnormalities, developmental delay, intellectual disability, multiple exostoses, and biparietal foramina</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>PHF21A</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">H3K4</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Recognition</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Schizophrenia (SCZD)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">181500</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hallucinations and delusions, severely inappropriate emotional responses, disordered thinking and concentration, erratic behavior, as well as social and occupational deterioration</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>SETD1A</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">H3K4</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Siderius X-linked mental retardation syndrome (MRXSSD)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">300263</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mental retardation, a repaired cleft lip, a long face with broad nasal tip, long hands with long thin fingers, and flat feet with long thin toes</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>PHF8</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">H3K4 H3K9 H4K20</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Recognition Demethylase Demethylase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Sotos syndrome 1 (SOTOS1)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">117550</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Excessively rapid growth, acromegalic features, and non-progressive cerebral disorder with mental retardation</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>NSD1</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">H3K36</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Weaver syndrome (WVS)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">277590</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Pre- and postnatal overgrowth, accelerated osseous maturation, characteristic craniofacial appearance, and developmental delay, broad forehead and face, ocular hypertelorism, prominent wide philtrum, micrognathia, deep horizontal chin groove, and deep-set nails</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>EZH2</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">H3K27</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Wiedemann-Steiner syndrome (WDSTS)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">605130</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hypertrichosis cubiti associated with short stature, consistent facial features, including long eyelashes, thick or arched eyebrows with a lateral flare, down slanting and vertically narrow palpebral fissures, mild to moderate intellectual disability, behavioral difficulties, and hypertrichosis on the back</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>KMT2A</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">H3K4</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Wolf-Hirschhorn syndrome (WHS)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">194190</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Pre- and postnatal growth deficiency, developmental disability of variable degree, characteristic craniofacial features, and a seizure disorder</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>NSD2</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">H3K36</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Methyltransferase</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>